<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Kwyllie</id>
		<title>LMU BioDB 2015 - User contributions [en]</title>
		<link rel="self" type="application/atom+xml" href="https://xmlpipedb.lmucs.io/biodb/fall2015/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Kwyllie"/>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php/Special:Contributions/Kwyllie"/>
		<updated>2026-05-03T17:14:25Z</updated>
		<subtitle>User contributions</subtitle>
		<generator>MediaWiki 1.25.1</generator>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS_Deliverables&amp;diff=8178</id>
		<title>GENialOMICS Deliverables</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS_Deliverables&amp;diff=8178"/>
				<updated>2015-12-18T23:33:08Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added my reflection.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Group Files and Datasets =&lt;br /&gt;
&lt;br /&gt;
* [[Media:Bc-Std GEN Build4 20151204.zip|GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;) (compressed)]]&lt;br /&gt;
* [[Media:ReadMe_Bc-Std_GEN_Build4_20151214_final.pdf|ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)]]&lt;br /&gt;
** [[Media: Genialomics-DatabaseSchema-20151211.pdf|Gene Database Schema Diagram]]&lt;br /&gt;
* [[media:GÉNialOMICS_Gene_Database_Testing_Report_(Build_4_Export)_-_LMU_BioDB_2015.pdf|Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)]]&lt;br /&gt;
* [[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)]]&lt;br /&gt;
* [[media:For_genMAPP_KWVP20151205.txt|Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)]]&lt;br /&gt;
* [[media:KWVP20151205.gex|GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)]]&lt;br /&gt;
* [[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)]]&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|Increase]]&lt;br /&gt;
** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|Decrease]]&lt;br /&gt;
* [[media:KWVP20151205.gmf|&amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file]]&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
** [[media:KWVP_MAPPfinder_20151208-increase-GO.xlsx|Increase]]&lt;br /&gt;
** [[media:Vpkwmappfinder20151205-Criterion1-GO-decreased.xlsx|Decrease]]&lt;br /&gt;
*[[media:Oxphosmappkwvp20151212.mapp|Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)]]&lt;br /&gt;
* [[Media:BioDBFinalReport-Genialomics.pdf | Group Report]] &lt;br /&gt;
* [[Media:Genialomics-BioDBFinalPresentation.pdf|Final PowerPoint presentation]]&lt;br /&gt;
&lt;br /&gt;
==Individual Assessments and Reflections==&lt;br /&gt;
*[[Media:ReflectionForFinalProject-AV.pdf | Anindita Varshneya]]&lt;br /&gt;
*[[Media:KWreflection.pdf | Kevin Wyllie]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWreflection.pdf&amp;diff=8176</id>
		<title>File:KWreflection.pdf</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWreflection.pdf&amp;diff=8176"/>
				<updated>2015-12-18T23:32:21Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: PDF for my reflection.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;PDF for my reflection.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7918</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7918"/>
				<updated>2015-12-15T07:19:40Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Finished my reflection.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Final Presentation ==&lt;br /&gt;
&lt;br /&gt;
[[Media:Genialomics-BioDBFinalPresentation.pdf | GENialOMICS Final Presentation]]&lt;br /&gt;
&lt;br /&gt;
== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
#* This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Filtered GO List ===&lt;br /&gt;
&lt;br /&gt;
*The GO term files above were opened in Excel, and the following filters were placed on the given columns:&lt;br /&gt;
** Z score: greater than 2&lt;br /&gt;
** PermuteP: less than 0.05&lt;br /&gt;
** Number changed: greater than or equal to 4 AND less than 100&lt;br /&gt;
** Percent changed: great than or equal to 15&lt;br /&gt;
* Values in the following columns were recorded:&lt;br /&gt;
** Number Changed&lt;br /&gt;
** Number Measured&lt;br /&gt;
** Number in GO&lt;br /&gt;
** Percent Changed&lt;br /&gt;
** Percent Present&lt;br /&gt;
** PermuteP&lt;br /&gt;
** AdjustedP&lt;br /&gt;
* Some of the above filter criteria had to be adjusted to attain 16 non-redundant GO terms. A list of these terms is shown below. For those terms which did not exactly fit this initial criteria, the altered criteria is apparent in the values on the table.&lt;br /&gt;
[[file:KWVP_GOterms.jpg|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png|center]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Reflection ==&lt;br /&gt;
&lt;br /&gt;
=== Statement of Work ===&lt;br /&gt;
&lt;br /&gt;
The goal of this project was to create a gene database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; and to use this database for the purpose of conducting an analysis on microarray data generated by Van Acker et al (2013). This data measured the transcriptomic effects of tobramycin (an antibiotic) on the bacterium. The database was constructed using data from [http://www.burkholderia.com/ Burkholderia Genome Database], [http://www.uniprot.org/ UniProt] and [http://geneontology.org/ Gene Ontology Consortium]. The microarray data was taken from the paper, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species]. Once the gene database (found [[Media:Bc-Std_GEN_20151204.zip|here]]) was created, the processed microarray data (found [[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|here]]) were fed through a software called GenMAPP, which analyzed the data and returned significantly changed cellular processes (gene ontology terms - see above for files and results). We then compared the biological implications of our analysis to that of Van Acker et al (2013).&lt;br /&gt;
&lt;br /&gt;
=== Assessment of Project ===&lt;br /&gt;
&lt;br /&gt;
This project, I think, was a success. I can&amp;#039;t speak for the QA and Coder (though the process seemed to go smoothly for them as well), but Veronica and I faced a healthy difficulty curve (substantial, yet reasonable) in processing and analyzing the microarray data. The only thing that &amp;quot;didn&amp;#039;t&amp;quot; work for us was initially proceeding further than we should&amp;#039;ve with statistical analysis, which ended up being a waste of time as we had not properly accounted for the multitude of technical replicates within our data. But retracing our steps wasn&amp;#039;t horribly difficult. To be quite honest, if I were to do this project again, the only thing I would change is that I would stress out about it less, because it was much easier than I had expected! &lt;br /&gt;
&lt;br /&gt;
I believe the quality of our work was high. We got slightly ahead of schedule, and thus had more time afterward to carefully examine our methods and verify that we had processed the data correctly. The organization may have been the most difficult part at first, managing between my individual page and the group page. The requirements for the group page initially seemed overwhelming, but it wasn&amp;#039;t a problem in the end. We certainly completed all of the &amp;quot;milestones&amp;quot; in this project. Again, this was not an issue because we overestimated the difficult of this project and thus spent ample time on it.&lt;br /&gt;
&lt;br /&gt;
=== Reflection on the Process ===&lt;br /&gt;
&lt;br /&gt;
* What did you learn?&lt;br /&gt;
** With your head?&lt;br /&gt;
*** I learned a lot about the microbial response to certain antibiotics! But more broadly, this project gave me a deeper understanding of the importance of deeply comprehending the scientific reasons for carrying out each step in the process of analyzing results. &lt;br /&gt;
** With your heart?&lt;br /&gt;
*** I think this project taught me a lot about how to communicate with people of different skillsets. Although every student in the class did the same assignments before this project, upon beginning this project we each re-familiarized ourselves with the appropriate processes to carry out our specific roles (and, being busy college students, &amp;#039;&amp;#039;only&amp;#039;&amp;#039; those necessary processes). Thus, when communicating with Anu and Brandon, I had to find ways to explain my part of the project to someone who didn&amp;#039;t know as much about the data processing protocols (and that&amp;#039;s totally ok; it wasn&amp;#039;t their responsibility to know these things, and this is mirrored in real workplace settings). Of course, when they communicated with Veronica and I, they had to water down their protocols as well.&lt;br /&gt;
** With your hands (technical skills)?&lt;br /&gt;
*** Every time I do microarray analysis-related tasks in Excel (whether in this class or with the Dahlquist Lab), it feels like I get a little better at it. And this project was no different. Excel, in general, is a skill that develops through repeated use, so that&amp;#039;s certainly a technical skill I developed further. However, in this project we faced the added difficulty of knowing that nobody more experienced than Veronica and I would be checking our work as closely. So there was more pressure, but it just meant that we scrutinized our work more closely, which only added to the learning experience.&lt;br /&gt;
* What lesson will you take away from this project that you will still use a year from now?&lt;br /&gt;
** A deeper understanding of the scientific principles behind microarray analysis, particularly with respect to how it is processed. While I may not be &amp;#039;&amp;#039;carrying out&amp;#039;&amp;#039; microarray analyses upon graduating from LMU (and thus graduating from the Dahlquist Lab), it seems like this technology will become even more pervasive within the field of biology, so and understanding of its inner-workings will be useful. Who knows? It may even become a standard method in medicinal science!&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7889</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7889"/>
				<updated>2015-12-15T05:59:50Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added the assessment of the project.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Final Presentation ==&lt;br /&gt;
&lt;br /&gt;
[[Media:Genialomics-BioDBFinalPresentation.pdf | GENialOMICS Final Presentation]]&lt;br /&gt;
&lt;br /&gt;
== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
#* This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Filtered GO List ===&lt;br /&gt;
&lt;br /&gt;
*The GO term files above were opened in Excel, and the following filters were placed on the given columns:&lt;br /&gt;
** Z score: greater than 2&lt;br /&gt;
** PermuteP: less than 0.05&lt;br /&gt;
** Number changed: greater than or equal to 4 AND less than 100&lt;br /&gt;
** Percent changed: great than or equal to 15&lt;br /&gt;
* Values in the following columns were recorded:&lt;br /&gt;
** Number Changed&lt;br /&gt;
** Number Measured&lt;br /&gt;
** Number in GO&lt;br /&gt;
** Percent Changed&lt;br /&gt;
** Percent Present&lt;br /&gt;
** PermuteP&lt;br /&gt;
** AdjustedP&lt;br /&gt;
* Some of the above filter criteria had to be adjusted to attain 16 non-redundant GO terms. A list of these terms is shown below. For those terms which did not exactly fit this initial criteria, the altered criteria is apparent in the values on the table.&lt;br /&gt;
[[file:KWVP_GOterms.jpg|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png|center]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Reflection ==&lt;br /&gt;
&lt;br /&gt;
=== Statement of Work ===&lt;br /&gt;
&lt;br /&gt;
The goal of this project was to create a gene database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; and to use this database for the purpose of conducting an analysis on microarray data generated by Van Acker et al (2013). This data measured the transcriptomic effects of tobramycin (an antibiotic) on the bacterium. The database was constructed using data from [http://www.burkholderia.com/ Burkholderia Genome Database], [http://www.uniprot.org/ UniProt] and [http://geneontology.org/ Gene Ontology Consortium]. The microarray data was taken from the paper, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species]. Once the gene database (found [[Media:Bc-Std_GEN_20151204.zip|here]]) was created, the processed microarray data (found [[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|here]]) were fed through a software called GenMAPP, which analyzed the data and returned significantly changed cellular processes (gene ontology terms - see above for files and results). We then compared the biological implications of our analysis to that of Van Acker et al (2013).&lt;br /&gt;
&lt;br /&gt;
=== Assessment of Project ===&lt;br /&gt;
&lt;br /&gt;
This project, I think, was a success. I can&amp;#039;t speak for the QA and Coder (though the process seemed to go smoothly for them as well), but Veronica and I faced a healthy difficulty curve (substantial, yet reasonable) in processing and analyzing the microarray data. The only thing that &amp;quot;didn&amp;#039;t&amp;quot; work for us was initially proceeding further than we should&amp;#039;ve with statistical analysis, which ended up being a waste of time as we had not properly accounted for the multitude of technical replicates within our data. But retracing our steps wasn&amp;#039;t horribly difficult. To be quite honest, if I were to do this project again, the only thing I would change is that I would stress out about it less, because it was much easier than I had expected! &lt;br /&gt;
&lt;br /&gt;
I believe the quality of our work was high. We got slightly ahead of schedule, and thus had more time afterward to carefully examine our methods and verify that we had processed the data correctly. The organization may have been the most difficult part at first, managing between my individual page and the group page. The requirements for the group page initially seemed overwhelming, but it wasn&amp;#039;t a problem in the end. We certainly completed all of the &amp;quot;milestones&amp;quot; in this project. Again, this was not an issue because we overestimated the difficult of this project and thus spent ample time on it.&lt;br /&gt;
&lt;br /&gt;
=== Reflection on the Process ===&lt;br /&gt;
&lt;br /&gt;
* What did you learn?&lt;br /&gt;
** With your head (biological or computer science principles)&lt;br /&gt;
** With your heart (personal qualities and teamwork qualities that make things work or not work)?&lt;br /&gt;
** With your hands (technical skills)?&lt;br /&gt;
* What lesson will you take away from this project that you will still use a year from now?&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7884</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7884"/>
				<updated>2015-12-15T05:32:38Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Edited the statement of work.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Final Presentation ==&lt;br /&gt;
&lt;br /&gt;
[[Media:Genialomics-BioDBFinalPresentation.pdf | GENialOMICS Final Presentation]]&lt;br /&gt;
&lt;br /&gt;
== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
#* This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Filtered GO List ===&lt;br /&gt;
&lt;br /&gt;
*The GO term files above were opened in Excel, and the following filters were placed on the given columns:&lt;br /&gt;
** Z score: greater than 2&lt;br /&gt;
** PermuteP: less than 0.05&lt;br /&gt;
** Number changed: greater than or equal to 4 AND less than 100&lt;br /&gt;
** Percent changed: great than or equal to 15&lt;br /&gt;
* Values in the following columns were recorded:&lt;br /&gt;
** Number Changed&lt;br /&gt;
** Number Measured&lt;br /&gt;
** Number in GO&lt;br /&gt;
** Percent Changed&lt;br /&gt;
** Percent Present&lt;br /&gt;
** PermuteP&lt;br /&gt;
** AdjustedP&lt;br /&gt;
* Some of the above filter criteria had to be adjusted to attain 16 non-redundant GO terms. A list of these terms is shown below. For those terms which did not exactly fit this initial criteria, the altered criteria is apparent in the values on the table.&lt;br /&gt;
[[file:KWVP_GOterms.jpg|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png|center]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Reflection ==&lt;br /&gt;
&lt;br /&gt;
=== Statement of Work ===&lt;br /&gt;
&lt;br /&gt;
The goal of this project was to create a gene database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; and to use this database for the purpose of conducting an analysis on microarray data generated by Van Acker et al (2013). This data measured the transcriptomic effects of tobramycin (an antibiotic) on the bacterium. The database was constructed using data from [http://www.burkholderia.com/ Burkholderia Genome Database], [http://www.uniprot.org/ UniProt] and [http://geneontology.org/ Gene Ontology Consortium]. The microarray data was taken from the paper, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species]. Once the gene database (found [[Media:Bc-Std_GEN_20151204.zip|here]]) was created, the processed microarray data (found [[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|here]]) were fed through a software called GenMAPP, which analyzed the data and returned significantly changed cellular processes (gene ontology terms - see above for files and results). We then compared the biological implications of our analysis to that of Van Acker et al (2013).&lt;br /&gt;
&lt;br /&gt;
=== Assessment of Project ===&lt;br /&gt;
&lt;br /&gt;
* Give an objective assessment of the success of your project workflow and teamwork.  &lt;br /&gt;
* What worked and what didn&amp;#039;t work?  &lt;br /&gt;
* What would you do differently if you could do it all over again?&lt;br /&gt;
* Evaluate the Gene Database Project and Group Report in the following areas:&lt;br /&gt;
*# Content: What is the quality of the work? &lt;br /&gt;
*# Organization: Comment on the organization of the project and of your group&amp;#039;s wiki pages.&lt;br /&gt;
*# Completeness:  Did your team achieve all of the project objectives?  Why or why not?&lt;br /&gt;
&lt;br /&gt;
=== Reflection on the Process ===&lt;br /&gt;
&lt;br /&gt;
* What did you learn?&lt;br /&gt;
** With your head (biological or computer science principles)&lt;br /&gt;
** With your heart (personal qualities and teamwork qualities that make things work or not work)?&lt;br /&gt;
** With your hands (technical skills)?&lt;br /&gt;
* What lesson will you take away from this project that you will still use a year from now?&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7883</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7883"/>
				<updated>2015-12-15T05:30:44Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added the statement of work.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Final Presentation ==&lt;br /&gt;
&lt;br /&gt;
[[Media:Genialomics-BioDBFinalPresentation.pdf | GENialOMICS Final Presentation]]&lt;br /&gt;
&lt;br /&gt;
== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
#* This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Filtered GO List ===&lt;br /&gt;
&lt;br /&gt;
*The GO term files above were opened in Excel, and the following filters were placed on the given columns:&lt;br /&gt;
** Z score: greater than 2&lt;br /&gt;
** PermuteP: less than 0.05&lt;br /&gt;
** Number changed: greater than or equal to 4 AND less than 100&lt;br /&gt;
** Percent changed: great than or equal to 15&lt;br /&gt;
* Values in the following columns were recorded:&lt;br /&gt;
** Number Changed&lt;br /&gt;
** Number Measured&lt;br /&gt;
** Number in GO&lt;br /&gt;
** Percent Changed&lt;br /&gt;
** Percent Present&lt;br /&gt;
** PermuteP&lt;br /&gt;
** AdjustedP&lt;br /&gt;
* Some of the above filter criteria had to be adjusted to attain 16 non-redundant GO terms. A list of these terms is shown below. For those terms which did not exactly fit this initial criteria, the altered criteria is apparent in the values on the table.&lt;br /&gt;
[[file:KWVP_GOterms.jpg|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png|center]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Reflection ==&lt;br /&gt;
&lt;br /&gt;
=== Statement of Work ===&lt;br /&gt;
&lt;br /&gt;
The goal of this project was to create a gene database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; and to use this database for the purpose of conducting an analysis on microarray data generated by Van Acker et al (2013). This data measured the transcriptomic effects of tobramycin (an antibiotic) on the bacterium. The database was constructed using data from [http://www.burkholderia.com/ Burkholderia Genome Database], [http://www.uniprot.org/ UniProt] and [http://geneontology.org/ Gene Ontology Consortium]. The microarray data was taken from the paper, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species]. Once the gene database (found [[Media:Bc-Std_GEN_20151204.zip|here]]) was created, the processed microarray data (found [[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|here]]) were fed through a software called GenMAPP, which analyzed the data and returned significantly changed cellular processes (gene ontology terms - see [[Kevin Wyllie Week 15|week 15 journal]] for files and results). We then compared the biological implications of our analysis to that of Van Acker et al (2013).&lt;br /&gt;
&lt;br /&gt;
=== Assessment of Project ===&lt;br /&gt;
&lt;br /&gt;
* Give an objective assessment of the success of your project workflow and teamwork.  &lt;br /&gt;
* What worked and what didn&amp;#039;t work?  &lt;br /&gt;
* What would you do differently if you could do it all over again?&lt;br /&gt;
* Evaluate the Gene Database Project and Group Report in the following areas:&lt;br /&gt;
*# Content: What is the quality of the work? &lt;br /&gt;
*# Organization: Comment on the organization of the project and of your group&amp;#039;s wiki pages.&lt;br /&gt;
*# Completeness:  Did your team achieve all of the project objectives?  Why or why not?&lt;br /&gt;
&lt;br /&gt;
=== Reflection on the Process ===&lt;br /&gt;
&lt;br /&gt;
* What did you learn?&lt;br /&gt;
** With your head (biological or computer science principles)&lt;br /&gt;
** With your heart (personal qualities and teamwork qualities that make things work or not work)?&lt;br /&gt;
** With your hands (technical skills)?&lt;br /&gt;
* What lesson will you take away from this project that you will still use a year from now?&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7870</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7870"/>
				<updated>2015-12-15T04:14:11Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added the link for our final presentation.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Final Presentation ==&lt;br /&gt;
&lt;br /&gt;
[[Media:Genialomics-BioDBFinalPresentation.pdf | GENialOMICS Final Presentation]]&lt;br /&gt;
&lt;br /&gt;
== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
#* This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Filtered GO List ===&lt;br /&gt;
&lt;br /&gt;
*The GO term files above were opened in Excel, and the following filters were placed on the given columns:&lt;br /&gt;
** Z score: greater than 2&lt;br /&gt;
** PermuteP: less than 0.05&lt;br /&gt;
** Number changed: greater than or equal to 4 AND less than 100&lt;br /&gt;
** Percent changed: great than or equal to 15&lt;br /&gt;
* Values in the following columns were recorded:&lt;br /&gt;
** Number Changed&lt;br /&gt;
** Number Measured&lt;br /&gt;
** Number in GO&lt;br /&gt;
** Percent Changed&lt;br /&gt;
** Percent Present&lt;br /&gt;
** PermuteP&lt;br /&gt;
** AdjustedP&lt;br /&gt;
* Some of the above filter criteria had to be adjusted to attain 16 non-redundant GO terms. A list of these terms is shown below. For those terms which did not exactly fit this initial criteria, the altered criteria is apparent in the values on the table.&lt;br /&gt;
[[file:KWVP_GOterms.jpg|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png|center]]&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7827</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7827"/>
				<updated>2015-12-14T21:22:06Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Typo fix.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
#* This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Filtered GO List ===&lt;br /&gt;
&lt;br /&gt;
*The GO term files above were opened in Excel, and the following filters were placed on the given columns:&lt;br /&gt;
** Z score: greater than 2&lt;br /&gt;
** PermuteP: less than 0.05&lt;br /&gt;
** Number changed: greater than or equal to 4 AND less than 100&lt;br /&gt;
** Percent changed: great than or equal to 15&lt;br /&gt;
* Values in the following columns were recorded:&lt;br /&gt;
** Number Changed&lt;br /&gt;
** Number Measured&lt;br /&gt;
** Number in GO&lt;br /&gt;
** Percent Changed&lt;br /&gt;
** Percent Present&lt;br /&gt;
** PermuteP&lt;br /&gt;
** AdjustedP&lt;br /&gt;
* Some of the above filter criteria had to be adjusted to attain 16 non-redundant GO terms. A list of these terms is shown below. For those terms which did not exactly fit this initial criteria, the altered criteria is apparent in the values on the table.&lt;br /&gt;
[[file:KWVP_GOterms.jpg|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png|center]]&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7826</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7826"/>
				<updated>2015-12-14T20:29:28Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Changed the GO table to a thumbnail since it&amp;#039;s huge.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
#* This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Filtered GO List ===&lt;br /&gt;
&lt;br /&gt;
*The GO term files above were opened in Excel, and the following filters were placed on the given columns:&lt;br /&gt;
** Z score: greater than 2&lt;br /&gt;
** PermuteP: less than 0.05&lt;br /&gt;
** Number changed: greater than or equal to 4 AND less than 100&lt;br /&gt;
** Percent changed: great than or equal to 15%&lt;br /&gt;
* Values in the following columns were recorded:&lt;br /&gt;
** Number Changed&lt;br /&gt;
** Number Measured&lt;br /&gt;
** Number in GO&lt;br /&gt;
** Percent Changed&lt;br /&gt;
** Percent Present&lt;br /&gt;
** PermuteP&lt;br /&gt;
** AdjustedP&lt;br /&gt;
* Some of the above filter criteria had to be adjusted to attain 16 non-redundant GO terms. A list of these terms is shown below. For those terms which did not exactly fit this initial criteria, the altered criteria is apparent in the values on the table.&lt;br /&gt;
[[file:KWVP_GOterms.jpg|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png|center]]&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7825</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7825"/>
				<updated>2015-12-14T20:29:08Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added the filtered GO list and its protocol.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
#* This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Filtered GO List ===&lt;br /&gt;
&lt;br /&gt;
*The GO term files above were opened in Excel, and the following filters were placed on the given columns:&lt;br /&gt;
** Z score: greater than 2&lt;br /&gt;
** PermuteP: less than 0.05&lt;br /&gt;
** Number changed: greater than or equal to 4 AND less than 100&lt;br /&gt;
** Percent changed: great than or equal to 15%&lt;br /&gt;
* Values in the following columns were recorded:&lt;br /&gt;
** Number Changed&lt;br /&gt;
** Number Measured&lt;br /&gt;
** Number in GO&lt;br /&gt;
** Percent Changed&lt;br /&gt;
** Percent Present&lt;br /&gt;
** PermuteP&lt;br /&gt;
** AdjustedP&lt;br /&gt;
* Some of the above filter criteria had to be adjusted to attain 16 non-redundant GO terms. A list of these terms is shown below. For those terms which did not exactly fit this initial criteria, the altered criteria is apparent in the values on the table.&lt;br /&gt;
[[file:KWVP_GOterms.jpg|center]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png|center]]&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP_GOterms.jpg&amp;diff=7824</id>
		<title>File:KWVP GOterms.jpg</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP_GOterms.jpg&amp;diff=7824"/>
				<updated>2015-12-14T20:08:08Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Our list of 16 significantly changed GO terms from the filtered increase and decrease GO lists.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Our list of 16 significantly changed GO terms from the filtered increase and decrease GO lists.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7823</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7823"/>
				<updated>2015-12-14T20:04:50Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Syntax.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
#* This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png|center]]&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS_Deliverables&amp;diff=7720</id>
		<title>GENialOMICS Deliverables</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS_Deliverables&amp;diff=7720"/>
				<updated>2015-12-13T01:15:19Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Syntax fix.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Group Files and Datasets ==&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* [[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)]]&lt;br /&gt;
* [[media:For_genMAPP_KWVP20151205.txt|Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)]]&lt;br /&gt;
* [[media:KWVP20151205.gex|GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)]]&lt;br /&gt;
* [[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)]]&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|Decrease]]&lt;br /&gt;
** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|Increase]]&lt;br /&gt;
* [[media:KWVP20151205.gmf|&amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file]]&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
** [[media:KWVP_MAPPfinder_20151208-increase-GO.xlsx|Increase]]&lt;br /&gt;
** Decrease&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS_Deliverables&amp;diff=7719</id>
		<title>GENialOMICS Deliverables</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS_Deliverables&amp;diff=7719"/>
				<updated>2015-12-13T01:14:34Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added a bunch of deliverables.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Group Files and Datasets ==&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* [[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)]]&lt;br /&gt;
* [[media:For_genMAPP_KWVP20151205.txt|Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)]]&lt;br /&gt;
* [[media:KWVP20151205.gex|GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)]]&lt;br /&gt;
* [[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)]]&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|Decrease]]&lt;br /&gt;
** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|Increase]]&lt;br /&gt;
* [[media:KWVP20151205.gmf|&amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file]]&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
** [[KWVP_MAPPfinder_20151208-increase-GO.xlsx|Increase]]&lt;br /&gt;
** Decrease&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP_MAPPfinder_20151208-increase-GO.xlsx&amp;diff=7718</id>
		<title>File:KWVP MAPPfinder 20151208-increase-GO.xlsx</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP_MAPPfinder_20151208-increase-GO.xlsx&amp;diff=7718"/>
				<updated>2015-12-13T01:14:08Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Filtered MAPPFinder results for the increased GO terms.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Filtered MAPPFinder results for the increased GO terms.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP20151205.gmf&amp;diff=7717</id>
		<title>File:KWVP20151205.gmf</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP20151205.gmf&amp;diff=7717"/>
				<updated>2015-12-13T01:13:16Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Our gmf file.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Our gmf file.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7716</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7716"/>
				<updated>2015-12-13T01:05:22Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Format fix.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
*# This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png|center]]&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7715</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7715"/>
				<updated>2015-12-13T01:04:17Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added sanity check image.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
*# This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVPSanitycheck2.png]]&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVPSanitycheck2.png&amp;diff=7714</id>
		<title>File:KWVPSanitycheck2.png</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVPSanitycheck2.png&amp;diff=7714"/>
				<updated>2015-12-13T01:04:00Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Another sanity check table.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Another sanity check table.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7713</id>
		<title>Kevin Wyllie Week 15</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_15&amp;diff=7713"/>
				<updated>2015-12-13T01:02:29Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added protocol and good practice links.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== MAPPFinder Procedure ===&lt;br /&gt;
&lt;br /&gt;
# MAPPFinder was launched from the GenMAPP window: &amp;quot;Tools&amp;quot; &amp;gt; &amp;quot;MAPPFinder&amp;quot;.&lt;br /&gt;
# &amp;quot;Calculate New Results&amp;quot; was selected from the MAPPFinder window.&lt;br /&gt;
# &amp;quot;Find File&amp;quot; was selected and in the directory, the .gex file (created in the Expression Dataset Manager - see week 14) was selected. &lt;br /&gt;
*# This file can be found [[media:KWVP20151205.gex|here]].&lt;br /&gt;
# Under the &amp;quot;Select Color Set&amp;quot; field, &amp;quot;KWVP_20151205&amp;quot; was selected (the color set&amp;#039;s name in this case is the same as the .gex file&amp;#039;s name - and there&amp;#039;s only one color set in the .gex file).&lt;br /&gt;
# After the color set has been selected, under the &amp;quot;Select Criteria to filter by&amp;quot; field, either increase or decrease was chosen. &lt;br /&gt;
# The boxes for &amp;quot;Gene Ontology&amp;quot; and &amp;quot;Click here to calculate p values...&amp;quot; were checked.&lt;br /&gt;
# The location to save the resulting .txt file was selected with the &amp;quot;Browse&amp;quot; option toward the bottom of the window. Note that because this protocol was carried out both for increase and decrease, there were two text files generated in MAPPFinder.&lt;br /&gt;
# &amp;quot;Run MAPPFinder&amp;quot; was selected to generate the gene ontology tree (and the aforementioned .txt files).&lt;br /&gt;
#* The files generated can be found here:&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-decrease-GO.txt|For downregulated GO terms.]]&lt;br /&gt;
#** [[media:KWVP_MAPPfinder_20151208-increase-GO.txt|For upregulated GO terms.]]&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP_MAPPfinder_20151208-increase-GO.txt&amp;diff=7712</id>
		<title>File:KWVP MAPPfinder 20151208-increase-GO.txt</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP_MAPPfinder_20151208-increase-GO.txt&amp;diff=7712"/>
				<updated>2015-12-13T01:02:00Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Our GO file for the increased GO terms.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Our GO file for the increased GO terms.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP_MAPPfinder_20151208-decrease-GO.txt&amp;diff=7711</id>
		<title>File:KWVP MAPPfinder 20151208-decrease-GO.txt</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP_MAPPfinder_20151208-decrease-GO.txt&amp;diff=7711"/>
				<updated>2015-12-13T00:59:30Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Our GO file for downregulated genes.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Our GO file for downregulated genes.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7709</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7709"/>
				<updated>2015-12-13T00:40:21Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Updated goals and progress.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
*Further explore the various ID systems; verify previous findings&lt;br /&gt;
*Create expressions for Match/PGSQL that will assist in evaluating the quality of any exported databases&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Completed Milestone 1: Initial Database Export&lt;br /&gt;
*Completed Milestone 2: ID Pattern Definition and Verification (will be revisited for future work with modified forms of GenMAPP builder) &lt;br /&gt;
**Should talk to Anu about further steps involving TallyEngine/GenMAPP builder (organize more exports)&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:WEEK12FILES GEN BL.zip|Week 12 Files]]&lt;br /&gt;
*[[Media:ORIG GEN BL12.zip|Starting Files]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Week 14=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finish second build.&lt;br /&gt;
* Analyze results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Begin modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Start writing README and scientific paper (parts of deliverables).&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Perform database export on the second build and other builds of the customized genMAPP builder&lt;br /&gt;
* Determine, with Anu, what modifications must be done to GenMAPP builder/Tallyengine&lt;br /&gt;
* Find out why most of the data/gene-names were not captured in the &amp;quot;OrderedLocusNames&amp;quot; table of the PSQL database for Export 1&lt;br /&gt;
* Create testing reports on any builds created for the week.&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finished second build. &lt;br /&gt;
* Analyzed results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Began modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Finished third build.&lt;br /&gt;
* Customized Tally Engine to collect counts for ORF ID&amp;#039;s.&lt;br /&gt;
* Finished fourth build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* It was found that the gene names of interest existed under the label of &amp;quot;ORF&amp;quot; in the XML file (explained why they weren&amp;#039;t captured by GenMAPP builder)&lt;br /&gt;
* Created a streamlined general expression that can capture all of the IDs of interest; shared with Anu, assisted in the creation of Build 3/4 of the modified genmapp builder&lt;br /&gt;
* Found that XMLPipeDB Match gave 6 extra counts using the general expression for the IDs; excel MATCH command analysis was conducted and the discrepant IDs were found&lt;br /&gt;
* Completed gene database test reports for builds 2, 3, and 4&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 14]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 14]]&lt;br /&gt;
*[[GÉNialOMICS Gene Database Testing Report (Build 2 Export)|Build 2 Export Testing Report]]&lt;br /&gt;
*[[GÉNialOMICS Gene Database Testing Report (Build 3 Export)|Build 3 Export Testing Report]]&lt;br /&gt;
*[[GÉNialOMICS Gene Database Testing Report (Build 4 Export)|Build 4 Export Testing Report]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 14]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 14]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
Build 2 - with customized species profile:&lt;br /&gt;
* [[Media: Gmbuilder-genialomics-12012015-build-2.zip| gmbuilder-genialomics-12012015-build-2.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:22, 1 December 2015 (PST) &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 3 - picking up gene names from ORF instead of ordered locus&lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-3.zip | gmbuilder-genialomics-12032015-build-3.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 14:58, 3 December 2015 (PST)&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 4 - customized TallyEngine &lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-4.zip|gmbuilder-genialomics-12032015-build-4.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:18, 3 December 2015 (PST)&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:GEN BL14 20151201.zip|Files from work done on 12/01/15]]&lt;br /&gt;
*[[Media:GEN BL14 20151203.zip|Files from work done on 12/03/15]]&lt;br /&gt;
*[[Media:GEN BL14 20151204.zip|Files from work done on 12/04/15]]&lt;br /&gt;
*[[Media:GEN BL14 20151207.zip|Files from work done on 12/07/15]]&lt;br /&gt;
*[[Media:Bc-Std_GEN_20151204.zip|Compressed gdb from Build 4]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt; see Kevin&amp;#039;s section --&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; &lt;br /&gt;
*[[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Final processed/formatted microarray data spreadsheet]]&lt;br /&gt;
*[[media:For_genMAPP_KWVP20151205.txt|txt form of the forGenMAPP sheet]]&lt;br /&gt;
*[[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file from first export.]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
==Reflections==&lt;br /&gt;
===Anu Varshneya===&lt;br /&gt;
*What worked?&lt;br /&gt;
**In general, I think our group worked very well together! I think we are all motivated to get this project done well, and are communicating well with each other regarding our progress.&lt;br /&gt;
*What didn&amp;#039;t work?&lt;br /&gt;
**I think for the most part we did a great job. I think the only ideas I have moving forward is a little bit more planning in regards to how we plan to attack the writing and presentation portion of the project. I am not concerned about us getting it done on time and with good quality, just that we create a plan of attack soon so that everyone is on the same page. :)&lt;br /&gt;
*What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
**Though nothing has not worked, I think we will just talk tomorrow about how we want to approach the writing and the presentation and set up some group work times.&lt;br /&gt;
&lt;br /&gt;
===Kevin Wyllie===&lt;br /&gt;
# What worked?&lt;br /&gt;
#* Our initial GenMAPP import worked! 284 errors, which, out of 7251, does sound so bad to me!&lt;br /&gt;
# What didn&amp;#039;t work?&lt;br /&gt;
#* Maybe this isn&amp;#039;t actually an example of something not working, but our calculated fold changes were quite different (much lower in magnitude) from those reported in Van Acker et al&amp;#039;s paper. However, they had the same directions and generally saw the same relative trends (ie the relatively higher fold changes in the paper were among the higher in our data). Also, very few of the genes they considered significant (with their super-lenient criteria that results in 30% of the genes seeing significant changes) were significant by our criteria.&lt;br /&gt;
# What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
#* We just need to triple/quadruple check that our data processing protocol is legitimate. Other than that, there&amp;#039;s not much we can do in terms of fold changes. And for statistical significance, we potentially should reconsider heightening our BH P-value threshold above 0.05, as currently we&amp;#039;re only considering about 8% of the genes to see a significant change. But maybe this is not too low of a number.&lt;br /&gt;
&lt;br /&gt;
===Veronica Pacheco===&lt;br /&gt;
#What worked?&lt;br /&gt;
#* Right off the bat, our first run through GenMAPP worked. As expected, there were exceptions and it generated an EX.txt file. There were 284 errors. We then handed over the file to Brandon so we shall see if the number of errors can decrease.&lt;br /&gt;
#What didn&amp;#039;t work?&lt;br /&gt;
#*What we initially thought didn&amp;#039;t work or didn&amp;#039;t seem correct was that fact that our values for fold changes were much smaller than the values reported in Van Acker et al&amp;#039;s paper. The direction, for the majority, aligned with what was reported however the concrete values had large differences.&lt;br /&gt;
#What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
#*Initially, we went to make sure our methods were correct. We traced back our steps and made sure the calculations were done correctly.After we double checked, we then sought help from Dr. Dahlquist and Dr. Dionisio. From their response, it seems we should go over it one more time and if there is no source of error on our part, we continue the project with our fold changes.&lt;br /&gt;
&lt;br /&gt;
===Brandon Litvak===&lt;br /&gt;
#What worked?&lt;br /&gt;
#*I think a lot of things worked this week. Team work and communication was a great help in getting the bulk of this week&amp;#039;s work done. The initial exported database was not working as planned and, as a team, we discovered that the reason had to do with the fact that GenMAPP builder was utilizing the wrong type of gene name; this knowledge allowed us to create builds this week that happened to work fairly well. These new builds covered the gene names of interest and led to a relatively small amount errors in GenMAPP. I think that, above all, the thing that worked best this week was my team. We were able to communicate and collaborate very well. &lt;br /&gt;
#What didn&amp;#039;t work?&lt;br /&gt;
#*At the present moment, I can&amp;#039;t really think of things that really did not work. With respect to the gene database project for J2315, everything appears to be on track; I would say that the major problems that were encountered in Week 14 were resolved. I feel that all of the major work for the project is complete; all that remains, is to synthesize the work done in a paper and presentation. As a group, we did get little work done on the final deliverables (which should be the focus, for this week) but we did get a lot of valuable work done for the project. We haven&amp;#039;t managed to plan much regarding the final deliverables, either (but this is a minor issue). &lt;br /&gt;
#What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
#*We will need to meet as a group and discuss the state of the project. I personally feel really good about the work so far and it would be helpful to hear, with the bulk of the work done, how everyone else feels. Additionally, I think that we will need to plan out our approach for the final project as soon as possible. Once we have discussed the project and made a plan, I think that we should set aside some time to work on the group project, as a team. I will check in with the group members on Tuesday, share my major findings for the week, and discuss future courses of action (regarding the last bits of the project).&lt;br /&gt;
&lt;br /&gt;
=Week 15=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Fix any problems with the build&lt;br /&gt;
* Finish presentation&lt;br /&gt;
* Start paper&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Finish example MAPPs (one for increase and decrease). &lt;br /&gt;
* Create sanity check table (with P-values).&lt;br /&gt;
* Upload deliverables.&lt;br /&gt;
* Begin PowerPoint.&lt;br /&gt;
* Begin report. &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Created a new build to fix problem in TallyEngine&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 15]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 15]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 15]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 15]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
[[Media:ReadMe_Bc-Std_GEN_Build4_20151204.doc.zip | readMe_Bc-Std_GEN_Build4_20151204.doc.zip]] &amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:gmbuilder-genialomics-20151210-build-5.zip | gmbuilder-genialomics-20151210-build-5.zip]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:Genialomics-DatabaseSchema-20151211.pdf | Genialomics-DatabaseSchema-20151211.pdf]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt; &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; &lt;br /&gt;
* Generated sanity check table.&lt;br /&gt;
* Upload deliverables.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Deliverables=&lt;br /&gt;
=== Group Deliverables ===&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Sample ReadMe in Word format:  [[Media:ReadMe_Vc-Std_External_20131122.zip | ReadMe_Vc-Std_External_20131122.zip]]&lt;br /&gt;
** [https://github.com/lmu-bioinformatics/xmlpipedb/blob/readme/GenMAPP%20Gene%20Databases/V.%20cholerae/V.%20cholerae%2020101022/ReadMe.md Sample ReadMe in markdown (a work in progress)] &lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
*** Sample schema in Adobe Illustrator format:  [[Media:Vibrio_schema_20101022.zip | Vibrio_schema_20101022.zip]]&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)&lt;br /&gt;
* GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)&lt;br /&gt;
* Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* &amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP20151205.gex&amp;diff=7681</id>
		<title>File:KWVP20151205.gex</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP20151205.gex&amp;diff=7681"/>
				<updated>2015-12-12T23:19:51Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: The expression dataset file for our final project.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The expression dataset file for our final project.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7447</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7447"/>
				<updated>2015-12-08T06:05:18Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added a file.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
*Further explore the various ID systems; verify previous findings&lt;br /&gt;
*Create expressions for Match/PGSQL that will assist in evaluating the quality of any exported databases&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Completed Milestone 1: Initial Database Export&lt;br /&gt;
*Completed Milestone 2: ID Pattern Definition and Verification (will be revisited for future work with modified forms of GenMAPP builder) &lt;br /&gt;
**Should talk to Anu about further steps involving TallyEngine/GenMAPP builder (organize more exports)&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:WEEK12FILES GEN BL.zip|Week 12 Files]]&lt;br /&gt;
*[[Media:ORIG GEN BL12.zip|Starting Files]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Week 14=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finish second build.&lt;br /&gt;
* Analyze results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Begin modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Start writing README and scientific paper (parts of deliverables).&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Perform database export on the second build and other builds of the customized genMAPP builder&lt;br /&gt;
* Determine, with Anu, what modifications must be done to GenMAPP builder/Tallyengine&lt;br /&gt;
* Find out why most of the data/gene-names were not captured in the &amp;quot;OrderedLocusNames&amp;quot; table of the PSQL database for Export 1&lt;br /&gt;
* Perform testing report on any builds created for the week.&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finished second build. &lt;br /&gt;
* Analyzed results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Began modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Finished third build.&lt;br /&gt;
* Customized Tally Engine to collect counts for ORF ID&amp;#039;s.&lt;br /&gt;
* Finished fourth build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 14]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 14]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 14]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 14]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
Build 2 - with customized species profile:&lt;br /&gt;
* [[Media: Gmbuilder-genialomics-12012015-build-2.zip| gmbuilder-genialomics-12012015-build-2.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:22, 1 December 2015 (PST) &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 3 - picking up gene names from ORF instead of ordered locus&lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-3.zip | gmbuilder-genialomics-12032015-build-3.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 14:58, 3 December 2015 (PST)&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 4 - customized TallyEngine &lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-4.zip|gmbuilder-genialomics-12032015-build-4.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:18, 3 December 2015 (PST)&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:Bc-Std_GEN_20151204.zip|Compressed gdb from Build 4]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt; see Kevin&amp;#039;s section --&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; &lt;br /&gt;
*[[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Final processed/formatted microarray data spreadsheet]]&lt;br /&gt;
*[[media:For_genMAPP_KWVP20151205.txt|txt form of the forGenMAPP sheet]]&lt;br /&gt;
*[[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file from first export.]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
==Reflections==&lt;br /&gt;
===Anu Varshneya===&lt;br /&gt;
*What worked?&lt;br /&gt;
**In general, I think our group worked very well together! I think we are all motivated to get this project done well, and are communicating well with each other regarding our progress.&lt;br /&gt;
*What didn&amp;#039;t work?&lt;br /&gt;
**I think for the most part we did a great job. I think the only ideas I have moving forward is a little bit more planning in regards to how we plan to attack the writing and presentation portion of the project. I am not concerned about us getting it done on time and with good quality, just that we create a plan of attack soon so that everyone is on the same page. :)&lt;br /&gt;
*What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
**Though nothing has not worked, I think we will just talk tomorrow about how we want to approach the writing and the presentation and set up some group work times.&lt;br /&gt;
&lt;br /&gt;
===Kevin Wyllie===&lt;br /&gt;
# What worked?&lt;br /&gt;
#* Our initial GenMAPP import worked! 284 errors, which, out of 7251, does sound so bad to me!&lt;br /&gt;
# What didn&amp;#039;t work?&lt;br /&gt;
#* Maybe this isn&amp;#039;t actually an example of something not working, but our calculated fold changes were quite different (much lower in magnitude) from those reported in Van Acker et al&amp;#039;s paper. However, they had the same directions and generally saw the same relative trends (ie the relatively higher fold changes in the paper were among the higher in our data). Also, very few of the genes they considered significant (with their super-lenient criteria that results in 30% of the genes seeing significant changes) were significant by our criteria.&lt;br /&gt;
# What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
#* We just need to triple/quadruple check that our data processing protocol is legitimate. Other than that, there&amp;#039;s not much we can do in terms of fold changes. And for statistical significance, we potentially should reconsider heightening our BH P-value threshold above 0.05, as currently we&amp;#039;re only considering about 8% of the genes to see a significant change. But maybe this is not too low of a number.&lt;br /&gt;
&lt;br /&gt;
=Deliverables=&lt;br /&gt;
=== Group Deliverables ===&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Sample ReadMe in Word format:  [[Media:ReadMe_Vc-Std_External_20131122.zip | ReadMe_Vc-Std_External_20131122.zip]]&lt;br /&gt;
** [https://github.com/lmu-bioinformatics/xmlpipedb/blob/readme/GenMAPP%20Gene%20Databases/V.%20cholerae/V.%20cholerae%2020101022/ReadMe.md Sample ReadMe in markdown (a work in progress)] &lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
*** Sample schema in Adobe Illustrator format:  [[Media:Vibrio_schema_20101022.zip | Vibrio_schema_20101022.zip]]&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)&lt;br /&gt;
* GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)&lt;br /&gt;
* Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* &amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:For_genMAPP_KWVP20151205.txt&amp;diff=7446</id>
		<title>File:For genMAPP KWVP20151205.txt</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:For_genMAPP_KWVP20151205.txt&amp;diff=7446"/>
				<updated>2015-12-08T06:04:52Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: The txt for genmapp import.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The txt for genmapp import.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7445</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7445"/>
				<updated>2015-12-08T06:03:11Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: ANOTHER syntax fix.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
*Further explore the various ID systems; verify previous findings&lt;br /&gt;
*Create expressions for Match/PGSQL that will assist in evaluating the quality of any exported databases&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Completed Milestone 1: Initial Database Export&lt;br /&gt;
*Completed Milestone 2: ID Pattern Definition and Verification (will be revisited for future work with modified forms of GenMAPP builder) &lt;br /&gt;
**Should talk to Anu about further steps involving TallyEngine/GenMAPP builder (organize more exports)&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:WEEK12FILES GEN BL.zip|Week 12 Files]]&lt;br /&gt;
*[[Media:ORIG GEN BL12.zip|Starting Files]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Week 14=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finish second build.&lt;br /&gt;
* Analyze results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Begin modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Start writing README and scientific paper (parts of deliverables).&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Perform database export on the second build and other builds of the customized genMAPP builder&lt;br /&gt;
* Determine, with Anu, what modifications must be done to GenMAPP builder/Tallyengine&lt;br /&gt;
* Find out why most of the data/gene-names were not captured in the &amp;quot;OrderedLocusNames&amp;quot; table of the PSQL database for Export 1&lt;br /&gt;
* Perform testing report on any builds created for the week.&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finished second build. &lt;br /&gt;
* Analyzed results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Began modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Finished third build.&lt;br /&gt;
* Customized Tally Engine to collect counts for ORF ID&amp;#039;s.&lt;br /&gt;
* Finished fourth build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 14]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 14]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 14]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 14]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
Build 2 - with customized species profile:&lt;br /&gt;
* [[Media: Gmbuilder-genialomics-12012015-build-2.zip| gmbuilder-genialomics-12012015-build-2.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:22, 1 December 2015 (PST) &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 3 - picking up gene names from ORF instead of ordered locus&lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-3.zip | gmbuilder-genialomics-12032015-build-3.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 14:58, 3 December 2015 (PST)&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 4 - customized TallyEngine &lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-4.zip|gmbuilder-genialomics-12032015-build-4.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:18, 3 December 2015 (PST)&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:Bc-Std_GEN_20151204.zip|Compressed gdb from Build 4]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt; see Kevin&amp;#039;s section --&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; &lt;br /&gt;
*[[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Final processed/formatted microarray data spreadsheet]]&lt;br /&gt;
*[[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file from first export.]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
==Reflections==&lt;br /&gt;
===Anu Varshneya===&lt;br /&gt;
*What worked?&lt;br /&gt;
**In general, I think our group worked very well together! I think we are all motivated to get this project done well, and are communicating well with each other regarding our progress.&lt;br /&gt;
*What didn&amp;#039;t work?&lt;br /&gt;
**I think for the most part we did a great job. I think the only ideas I have moving forward is a little bit more planning in regards to how we plan to attack the writing and presentation portion of the project. I am not concerned about us getting it done on time and with good quality, just that we create a plan of attack soon so that everyone is on the same page. :)&lt;br /&gt;
*What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
**Though nothing has not worked, I think we will just talk tomorrow about how we want to approach the writing and the presentation and set up some group work times.&lt;br /&gt;
&lt;br /&gt;
===Kevin Wyllie===&lt;br /&gt;
# What worked?&lt;br /&gt;
#* Our initial GenMAPP import worked! 284 errors, which, out of 7251, does sound so bad to me!&lt;br /&gt;
# What didn&amp;#039;t work?&lt;br /&gt;
#* Maybe this isn&amp;#039;t actually an example of something not working, but our calculated fold changes were quite different (much lower in magnitude) from those reported in Van Acker et al&amp;#039;s paper. However, they had the same directions and generally saw the same relative trends (ie the relatively higher fold changes in the paper were among the higher in our data). Also, very few of the genes they considered significant (with their super-lenient criteria that results in 30% of the genes seeing significant changes) were significant by our criteria.&lt;br /&gt;
# What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
#* We just need to triple/quadruple check that our data processing protocol is legitimate. Other than that, there&amp;#039;s not much we can do in terms of fold changes. And for statistical significance, we potentially should reconsider heightening our BH P-value threshold above 0.05, as currently we&amp;#039;re only considering about 8% of the genes to see a significant change. But maybe this is not too low of a number.&lt;br /&gt;
&lt;br /&gt;
=Deliverables=&lt;br /&gt;
=== Group Deliverables ===&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Sample ReadMe in Word format:  [[Media:ReadMe_Vc-Std_External_20131122.zip | ReadMe_Vc-Std_External_20131122.zip]]&lt;br /&gt;
** [https://github.com/lmu-bioinformatics/xmlpipedb/blob/readme/GenMAPP%20Gene%20Databases/V.%20cholerae/V.%20cholerae%2020101022/ReadMe.md Sample ReadMe in markdown (a work in progress)] &lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
*** Sample schema in Adobe Illustrator format:  [[Media:Vibrio_schema_20101022.zip | Vibrio_schema_20101022.zip]]&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)&lt;br /&gt;
* GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)&lt;br /&gt;
* Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* &amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7443</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7443"/>
				<updated>2015-12-08T06:02:53Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Another syntax fix.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
*Further explore the various ID systems; verify previous findings&lt;br /&gt;
*Create expressions for Match/PGSQL that will assist in evaluating the quality of any exported databases&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Completed Milestone 1: Initial Database Export&lt;br /&gt;
*Completed Milestone 2: ID Pattern Definition and Verification (will be revisited for future work with modified forms of GenMAPP builder) &lt;br /&gt;
**Should talk to Anu about further steps involving TallyEngine/GenMAPP builder (organize more exports)&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:WEEK12FILES GEN BL.zip|Week 12 Files]]&lt;br /&gt;
*[[Media:ORIG GEN BL12.zip|Starting Files]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Week 14=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finish second build.&lt;br /&gt;
* Analyze results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Begin modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Start writing README and scientific paper (parts of deliverables).&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Perform database export on the second build and other builds of the customized genMAPP builder&lt;br /&gt;
* Determine, with Anu, what modifications must be done to GenMAPP builder/Tallyengine&lt;br /&gt;
* Find out why most of the data/gene-names were not captured in the &amp;quot;OrderedLocusNames&amp;quot; table of the PSQL database for Export 1&lt;br /&gt;
* Perform testing report on any builds created for the week.&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finished second build. &lt;br /&gt;
* Analyzed results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Began modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Finished third build.&lt;br /&gt;
* Customized Tally Engine to collect counts for ORF ID&amp;#039;s.&lt;br /&gt;
* Finished fourth build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 14]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 14]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 14]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 14]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
Build 2 - with customized species profile:&lt;br /&gt;
* [[Media: Gmbuilder-genialomics-12012015-build-2.zip| gmbuilder-genialomics-12012015-build-2.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:22, 1 December 2015 (PST) &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 3 - picking up gene names from ORF instead of ordered locus&lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-3.zip | gmbuilder-genialomics-12032015-build-3.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 14:58, 3 December 2015 (PST)&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 4 - customized TallyEngine &lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-4.zip|gmbuilder-genialomics-12032015-build-4.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:18, 3 December 2015 (PST)&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:Bc-Std_GEN_20151204.zip|Compressed gdb from Build 4]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt; see Kevin&amp;#039;s section --&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; &lt;br /&gt;
*[[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Final processed/formatted microarray data spreadsheet]]&lt;br /&gt;
*[[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file from first export.]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
==Reflections==&lt;br /&gt;
===Anu Varshneya===&lt;br /&gt;
*What worked?&lt;br /&gt;
**In general, I think our group worked very well together! I think we are all motivated to get this project done well, and are communicating well with each other regarding our progress.&lt;br /&gt;
*What didn&amp;#039;t work?&lt;br /&gt;
**I think for the most part we did a great job. I think the only ideas I have moving forward is a little bit more planning in regards to how we plan to attack the writing and presentation portion of the project. I am not concerned about us getting it done on time and with good quality, just that we create a plan of attack soon so that everyone is on the same page. :)&lt;br /&gt;
*What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
**Though nothing has not worked, I think we will just talk tomorrow about how we want to approach the writing and the presentation and set up some group work times.&lt;br /&gt;
&lt;br /&gt;
===Kevin Wyllie===&lt;br /&gt;
# What worked?&lt;br /&gt;
#* Our initial GenMAPP import worked! 284 errors, which, out of 7251, does sound so bad to me!&lt;br /&gt;
# What didn&amp;#039;t work?&lt;br /&gt;
#* Maybe this isn&amp;#039;t actually an example of something not working, but our calculated fold changes were quite different (much lower in magnitude) from those reported in Van Acker et al&amp;#039;s paper. However, they had the same directions and generally saw the same relative trends (ie the relatively higher fold changes in the paper were among the higher in our data). Also, very few of the genes they considered significant (with their super-lenient criteria that results in 30% of the genes seeing significant changes) were significant by our criteria.&lt;br /&gt;
# What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
*# We just need to triple/quadruple check that our data processing protocol is legitimate. Other than that, there&amp;#039;s not much we can do in terms of fold changes. And for statistical significance, we potentially should reconsider heightening our BH P-value threshold above 0.05, as currently we&amp;#039;re only considering about 8% of the genes to see a significant change. But maybe this is not too low of a number.&lt;br /&gt;
&lt;br /&gt;
=Deliverables=&lt;br /&gt;
=== Group Deliverables ===&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Sample ReadMe in Word format:  [[Media:ReadMe_Vc-Std_External_20131122.zip | ReadMe_Vc-Std_External_20131122.zip]]&lt;br /&gt;
** [https://github.com/lmu-bioinformatics/xmlpipedb/blob/readme/GenMAPP%20Gene%20Databases/V.%20cholerae/V.%20cholerae%2020101022/ReadMe.md Sample ReadMe in markdown (a work in progress)] &lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
*** Sample schema in Adobe Illustrator format:  [[Media:Vibrio_schema_20101022.zip | Vibrio_schema_20101022.zip]]&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)&lt;br /&gt;
* GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)&lt;br /&gt;
* Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* &amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7442</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7442"/>
				<updated>2015-12-08T06:02:37Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Another syntax fix.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
*Further explore the various ID systems; verify previous findings&lt;br /&gt;
*Create expressions for Match/PGSQL that will assist in evaluating the quality of any exported databases&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Completed Milestone 1: Initial Database Export&lt;br /&gt;
*Completed Milestone 2: ID Pattern Definition and Verification (will be revisited for future work with modified forms of GenMAPP builder) &lt;br /&gt;
**Should talk to Anu about further steps involving TallyEngine/GenMAPP builder (organize more exports)&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:WEEK12FILES GEN BL.zip|Week 12 Files]]&lt;br /&gt;
*[[Media:ORIG GEN BL12.zip|Starting Files]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Week 14=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finish second build.&lt;br /&gt;
* Analyze results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Begin modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Start writing README and scientific paper (parts of deliverables).&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Perform database export on the second build and other builds of the customized genMAPP builder&lt;br /&gt;
* Determine, with Anu, what modifications must be done to GenMAPP builder/Tallyengine&lt;br /&gt;
* Find out why most of the data/gene-names were not captured in the &amp;quot;OrderedLocusNames&amp;quot; table of the PSQL database for Export 1&lt;br /&gt;
* Perform testing report on any builds created for the week.&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finished second build. &lt;br /&gt;
* Analyzed results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Began modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Finished third build.&lt;br /&gt;
* Customized Tally Engine to collect counts for ORF ID&amp;#039;s.&lt;br /&gt;
* Finished fourth build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 14]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 14]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 14]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 14]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
Build 2 - with customized species profile:&lt;br /&gt;
* [[Media: Gmbuilder-genialomics-12012015-build-2.zip| gmbuilder-genialomics-12012015-build-2.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:22, 1 December 2015 (PST) &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 3 - picking up gene names from ORF instead of ordered locus&lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-3.zip | gmbuilder-genialomics-12032015-build-3.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 14:58, 3 December 2015 (PST)&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 4 - customized TallyEngine &lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-4.zip|gmbuilder-genialomics-12032015-build-4.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:18, 3 December 2015 (PST)&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:Bc-Std_GEN_20151204.zip|Compressed gdb from Build 4]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt; see Kevin&amp;#039;s section --&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; &lt;br /&gt;
*[[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Final processed/formatted microarray data spreadsheet]]&lt;br /&gt;
*[[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file from first export.]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
==Reflections==&lt;br /&gt;
===Anu Varshneya===&lt;br /&gt;
*What worked?&lt;br /&gt;
**In general, I think our group worked very well together! I think we are all motivated to get this project done well, and are communicating well with each other regarding our progress.&lt;br /&gt;
*What didn&amp;#039;t work?&lt;br /&gt;
**I think for the most part we did a great job. I think the only ideas I have moving forward is a little bit more planning in regards to how we plan to attack the writing and presentation portion of the project. I am not concerned about us getting it done on time and with good quality, just that we create a plan of attack soon so that everyone is on the same page. :)&lt;br /&gt;
*What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
**Though nothing has not worked, I think we will just talk tomorrow about how we want to approach the writing and the presentation and set up some group work times.&lt;br /&gt;
&lt;br /&gt;
===Kevin Wyllie===&lt;br /&gt;
# What worked?&lt;br /&gt;
#* Our initial GenMAPP import worked! 284 errors, which, out of 7251, does sound so bad to me!&lt;br /&gt;
# What didn&amp;#039;t work?&lt;br /&gt;
#* Maybe this isn&amp;#039;t actually an example of something not working, but our calculated fold changes were quite different (much lower in magnitude) from those reported in Van Acker et al&amp;#039;s paper. However, they had the same directions and generally saw the same relative trends (ie the relatively higher fold changes in the paper were among the higher in our data). Also, very few of the genes they considered significant (with their super-lenient criteria that results in 30% of the genes seeing significant changes) were significant by our criteria.&lt;br /&gt;
*# What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
*# We just need to triple/quadruple check that our data processing protocol is legitimate. Other than that, there&amp;#039;s not much we can do in terms of fold changes. And for statistical significance, we potentially should reconsider heightening our BH P-value threshold above 0.05, as currently we&amp;#039;re only considering about 8% of the genes to see a significant change. But maybe this is not too low of a number.&lt;br /&gt;
&lt;br /&gt;
=Deliverables=&lt;br /&gt;
=== Group Deliverables ===&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Sample ReadMe in Word format:  [[Media:ReadMe_Vc-Std_External_20131122.zip | ReadMe_Vc-Std_External_20131122.zip]]&lt;br /&gt;
** [https://github.com/lmu-bioinformatics/xmlpipedb/blob/readme/GenMAPP%20Gene%20Databases/V.%20cholerae/V.%20cholerae%2020101022/ReadMe.md Sample ReadMe in markdown (a work in progress)] &lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
*** Sample schema in Adobe Illustrator format:  [[Media:Vibrio_schema_20101022.zip | Vibrio_schema_20101022.zip]]&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)&lt;br /&gt;
* GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)&lt;br /&gt;
* Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* &amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7441</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7441"/>
				<updated>2015-12-08T06:02:13Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Syntax fix.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
*Further explore the various ID systems; verify previous findings&lt;br /&gt;
*Create expressions for Match/PGSQL that will assist in evaluating the quality of any exported databases&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Completed Milestone 1: Initial Database Export&lt;br /&gt;
*Completed Milestone 2: ID Pattern Definition and Verification (will be revisited for future work with modified forms of GenMAPP builder) &lt;br /&gt;
**Should talk to Anu about further steps involving TallyEngine/GenMAPP builder (organize more exports)&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:WEEK12FILES GEN BL.zip|Week 12 Files]]&lt;br /&gt;
*[[Media:ORIG GEN BL12.zip|Starting Files]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Week 14=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finish second build.&lt;br /&gt;
* Analyze results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Begin modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Start writing README and scientific paper (parts of deliverables).&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Perform database export on the second build and other builds of the customized genMAPP builder&lt;br /&gt;
* Determine, with Anu, what modifications must be done to GenMAPP builder/Tallyengine&lt;br /&gt;
* Find out why most of the data/gene-names were not captured in the &amp;quot;OrderedLocusNames&amp;quot; table of the PSQL database for Export 1&lt;br /&gt;
* Perform testing report on any builds created for the week.&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finished second build. &lt;br /&gt;
* Analyzed results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Began modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Finished third build.&lt;br /&gt;
* Customized Tally Engine to collect counts for ORF ID&amp;#039;s.&lt;br /&gt;
* Finished fourth build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 14]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 14]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 14]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 14]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
Build 2 - with customized species profile:&lt;br /&gt;
* [[Media: Gmbuilder-genialomics-12012015-build-2.zip| gmbuilder-genialomics-12012015-build-2.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:22, 1 December 2015 (PST) &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 3 - picking up gene names from ORF instead of ordered locus&lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-3.zip | gmbuilder-genialomics-12032015-build-3.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 14:58, 3 December 2015 (PST)&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 4 - customized TallyEngine &lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-4.zip|gmbuilder-genialomics-12032015-build-4.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:18, 3 December 2015 (PST)&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:Bc-Std_GEN_20151204.zip|Compressed gdb from Build 4]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt; see Kevin&amp;#039;s section --&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; &lt;br /&gt;
*[[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Final processed/formatted microarray data spreadsheet]]&lt;br /&gt;
*[[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file from first export.]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
==Reflections==&lt;br /&gt;
===Anu Varshneya===&lt;br /&gt;
*What worked?&lt;br /&gt;
**In general, I think our group worked very well together! I think we are all motivated to get this project done well, and are communicating well with each other regarding our progress.&lt;br /&gt;
*What didn&amp;#039;t work?&lt;br /&gt;
**I think for the most part we did a great job. I think the only ideas I have moving forward is a little bit more planning in regards to how we plan to attack the writing and presentation portion of the project. I am not concerned about us getting it done on time and with good quality, just that we create a plan of attack soon so that everyone is on the same page. :)&lt;br /&gt;
*What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
**Though nothing has not worked, I think we will just talk tomorrow about how we want to approach the writing and the presentation and set up some group work times.&lt;br /&gt;
&lt;br /&gt;
===Kevin Wyllie===&lt;br /&gt;
# What worked?&lt;br /&gt;
#* Our initial GenMAPP import worked! 284 errors, which, out of 7251, does sound so bad to me!&lt;br /&gt;
# What didn&amp;#039;t work?&lt;br /&gt;
#* Maybe this isn&amp;#039;t actually an example of something not working, but our calculated fold changes were quite different (much lower in magnitude) from those reported in Van Acker et al&amp;#039;s paper. However, they had the same directions and generally saw the same relative trends (ie the relatively higher fold changes in the paper were among the higher in our data). Also, very few of the genes they considered significant (with their super-lenient criteria that results in 30% of the genes seeing significant changes) were significant by our criteria.&lt;br /&gt;
*# What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
*#* We just need to triple/quadruple check that our data processing protocol is legitimate. Other than that, there&amp;#039;s not much we can do in terms of fold changes. And for statistical significance, we potentially should reconsider heightening our BH P-value threshold above 0.05, as currently we&amp;#039;re only considering about 8% of the genes to see a significant change. But maybe this is not too low of a number.&lt;br /&gt;
&lt;br /&gt;
=Deliverables=&lt;br /&gt;
=== Group Deliverables ===&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Sample ReadMe in Word format:  [[Media:ReadMe_Vc-Std_External_20131122.zip | ReadMe_Vc-Std_External_20131122.zip]]&lt;br /&gt;
** [https://github.com/lmu-bioinformatics/xmlpipedb/blob/readme/GenMAPP%20Gene%20Databases/V.%20cholerae/V.%20cholerae%2020101022/ReadMe.md Sample ReadMe in markdown (a work in progress)] &lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
*** Sample schema in Adobe Illustrator format:  [[Media:Vibrio_schema_20101022.zip | Vibrio_schema_20101022.zip]]&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)&lt;br /&gt;
* GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)&lt;br /&gt;
* Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* &amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7440</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7440"/>
				<updated>2015-12-08T06:01:57Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added my reflection responses.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
*Further explore the various ID systems; verify previous findings&lt;br /&gt;
*Create expressions for Match/PGSQL that will assist in evaluating the quality of any exported databases&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Completed Milestone 1: Initial Database Export&lt;br /&gt;
*Completed Milestone 2: ID Pattern Definition and Verification (will be revisited for future work with modified forms of GenMAPP builder) &lt;br /&gt;
**Should talk to Anu about further steps involving TallyEngine/GenMAPP builder (organize more exports)&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:WEEK12FILES GEN BL.zip|Week 12 Files]]&lt;br /&gt;
*[[Media:ORIG GEN BL12.zip|Starting Files]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Week 14=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finish second build.&lt;br /&gt;
* Analyze results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Begin modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Start writing README and scientific paper (parts of deliverables).&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Perform database export on the second build and other builds of the customized genMAPP builder&lt;br /&gt;
* Determine, with Anu, what modifications must be done to GenMAPP builder/Tallyengine&lt;br /&gt;
* Find out why most of the data/gene-names were not captured in the &amp;quot;OrderedLocusNames&amp;quot; table of the PSQL database for Export 1&lt;br /&gt;
* Perform testing report on any builds created for the week.&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finished second build. &lt;br /&gt;
* Analyzed results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Began modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Finished third build.&lt;br /&gt;
* Customized Tally Engine to collect counts for ORF ID&amp;#039;s.&lt;br /&gt;
* Finished fourth build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 14]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 14]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 14]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 14]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
Build 2 - with customized species profile:&lt;br /&gt;
* [[Media: Gmbuilder-genialomics-12012015-build-2.zip| gmbuilder-genialomics-12012015-build-2.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:22, 1 December 2015 (PST) &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 3 - picking up gene names from ORF instead of ordered locus&lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-3.zip | gmbuilder-genialomics-12032015-build-3.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 14:58, 3 December 2015 (PST)&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 4 - customized TallyEngine &lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-4.zip|gmbuilder-genialomics-12032015-build-4.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:18, 3 December 2015 (PST)&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:Bc-Std_GEN_20151204.zip|Compressed gdb from Build 4]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt; see Kevin&amp;#039;s section --&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; &lt;br /&gt;
*[[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Final processed/formatted microarray data spreadsheet]]&lt;br /&gt;
*[[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file from first export.]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
==Reflections==&lt;br /&gt;
===Anu Varshneya===&lt;br /&gt;
*What worked?&lt;br /&gt;
**In general, I think our group worked very well together! I think we are all motivated to get this project done well, and are communicating well with each other regarding our progress.&lt;br /&gt;
*What didn&amp;#039;t work?&lt;br /&gt;
**I think for the most part we did a great job. I think the only ideas I have moving forward is a little bit more planning in regards to how we plan to attack the writing and presentation portion of the project. I am not concerned about us getting it done on time and with good quality, just that we create a plan of attack soon so that everyone is on the same page. :)&lt;br /&gt;
*What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
**Though nothing has not worked, I think we will just talk tomorrow about how we want to approach the writing and the presentation and set up some group work times.&lt;br /&gt;
&lt;br /&gt;
===Kevin Wyllie===&lt;br /&gt;
*# What worked?&lt;br /&gt;
*#* Our initial GenMAPP import worked! 284 errors, which, out of 7251, does sound so bad to me!&lt;br /&gt;
*# What didn&amp;#039;t work?&lt;br /&gt;
*#* Maybe this isn&amp;#039;t actually an example of something not working, but our calculated fold changes were quite different (much lower in magnitude) from those reported in Van Acker et al&amp;#039;s paper. However, they had the same directions and generally saw the same relative trends (ie the relatively higher fold changes in the paper were among the higher in our data). Also, very few of the genes they considered significant (with their super-lenient criteria that results in 30% of the genes seeing significant changes) were significant by our criteria.&lt;br /&gt;
*# What will I do next to fix what didn&amp;#039;t work?&lt;br /&gt;
*#* We just need to triple/quadruple check that our data processing protocol is legitimate. Other than that, there&amp;#039;s not much we can do in terms of fold changes. And for statistical significance, we potentially should reconsider heightening our BH P-value threshold above 0.05, as currently we&amp;#039;re only considering about 8% of the genes to see a significant change. But maybe this is not too low of a number.&lt;br /&gt;
&lt;br /&gt;
=Deliverables=&lt;br /&gt;
=== Group Deliverables ===&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Sample ReadMe in Word format:  [[Media:ReadMe_Vc-Std_External_20131122.zip | ReadMe_Vc-Std_External_20131122.zip]]&lt;br /&gt;
** [https://github.com/lmu-bioinformatics/xmlpipedb/blob/readme/GenMAPP%20Gene%20Databases/V.%20cholerae/V.%20cholerae%2020101022/ReadMe.md Sample ReadMe in markdown (a work in progress)] &lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
*** Sample schema in Adobe Illustrator format:  [[Media:Vibrio_schema_20101022.zip | Vibrio_schema_20101022.zip]]&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)&lt;br /&gt;
* GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)&lt;br /&gt;
* Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* &amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7432</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7432"/>
				<updated>2015-12-08T05:51:20Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Minor formatting edit.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
*Further explore the various ID systems; verify previous findings&lt;br /&gt;
*Create expressions for Match/PGSQL that will assist in evaluating the quality of any exported databases&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Completed Milestone 1: Initial Database Export&lt;br /&gt;
*Completed Milestone 2: ID Pattern Definition and Verification (will be revisited for future work with modified forms of GenMAPP builder) &lt;br /&gt;
**Should talk to Anu about further steps involving TallyEngine/GenMAPP builder (organize more exports)&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:WEEK12FILES GEN BL.zip|Week 12 Files]]&lt;br /&gt;
*[[Media:ORIG GEN BL12.zip|Starting Files]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Week 14=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finish second build.&lt;br /&gt;
* Analyze results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Begin modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Start writing README and scientific paper (parts of deliverables).&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Perform database export on the second build and other builds of the customized genMAPP builder&lt;br /&gt;
* Determine, with Anu, what modifications must be done to GenMAPP builder/Tallyengine&lt;br /&gt;
* Find out why most of the data/gene-names were not captured in the &amp;quot;OrderedLocusNames&amp;quot; table of the PSQL database for Export 1&lt;br /&gt;
* Perform testing report on any builds created for the week.&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finished second build. &lt;br /&gt;
* Analyzed results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Began modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Finished third build.&lt;br /&gt;
* Customized Tally Engine to collect counts for ORF ID&amp;#039;s.&lt;br /&gt;
* Finished fourth build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 14]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 14]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 14]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 14]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
Build 2 - with customized species profile:&lt;br /&gt;
* [[Media: Gmbuilder-genialomics-12012015-build-2.zip| gmbuilder-genialomics-12012015-build-2.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:22, 1 December 2015 (PST) &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 3 - picking up gene names from ORF instead of ordered locus&lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-3.zip | gmbuilder-genialomics-12032015-build-3.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 14:58, 3 December 2015 (PST)&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 4 - customized TallyEngine &lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-4.zip|gmbuilder-genialomics-12032015-build-4.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:18, 3 December 2015 (PST)&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:Bc-Std_GEN_20151204.zip|Compressed gdb from Build 4]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt; see Kevin&amp;#039;s section --&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; &lt;br /&gt;
*[[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Final processed/formatted microarray data spreadsheet]]&lt;br /&gt;
*[[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file from first export.]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Deliverables=&lt;br /&gt;
=== Group Deliverables ===&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Sample ReadMe in Word format:  [[Media:ReadMe_Vc-Std_External_20131122.zip | ReadMe_Vc-Std_External_20131122.zip]]&lt;br /&gt;
** [https://github.com/lmu-bioinformatics/xmlpipedb/blob/readme/GenMAPP%20Gene%20Databases/V.%20cholerae/V.%20cholerae%2020101022/ReadMe.md Sample ReadMe in markdown (a work in progress)] &lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
*** Sample schema in Adobe Illustrator format:  [[Media:Vibrio_schema_20101022.zip | Vibrio_schema_20101022.zip]]&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)&lt;br /&gt;
* GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)&lt;br /&gt;
* Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* &amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7431</id>
		<title>Kevin Wyllie Week 14</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7431"/>
				<updated>2015-12-08T05:48:08Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added protocol for the first part of the GenMAPP import.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== Statistical Analysis and Formatting === &lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;We looked at Dr. Dahlquist&amp;#039;s comments on our prior worksheet to make a second attempt at processing and formatting for GenMAPP. Our biggest error in the the previous attempt was forgetting to account for the fact that each gene was spotted in (technical) quadruplicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Dr. Dahlquist prepared a sheet for us to start with, which separated each quadruplicate of the genome across columns. So the ID column for the first technical replicate was in column A, followed by fold change data for one of the four technical replicates within each of the biological replicates, for the (untreated) biofilm and tobramycin-treated biofilm samples. Next was the second ID column (identical to the first) in column J, followed by the second set of technical replicates within each biological replicate. These sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;quadruplicated_spots_separated&amp;#039;&amp;#039;&amp;#039;&amp;quot;.&lt;br /&gt;
# After all four sets of technical replicates, yet another ID column (column AK) was added, following by the averaged fold change values across each technical replicate (for each biological replicate - columns AL through AS). &lt;br /&gt;
#* For these averages the &amp;lt;code&amp;gt;=AVERAGE(*four technical replicates*)&amp;lt;/code&amp;gt; command was used and pasted through the entirety of each column. The *four technical replicates* is a placeholder for the cell coordinates corresponding to each technical replicate within a biological replicate.&lt;br /&gt;
#* Because all five untreated and all three treated samples will be averaged later in the protocol, the word &amp;quot;consolidated&amp;quot; (instead of &amp;quot;average&amp;quot;) was used in the headings for these columns. For example, the column heading for the first biological untreated sample was &amp;quot;consolidated_Biofilm_1_scaled_centered_4&amp;quot;.&lt;br /&gt;
# Next, a new sheet was created, named &amp;quot;&amp;#039;&amp;#039;&amp;#039;statistics&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet (using the &amp;quot;Paste Values&amp;quot; function) were the &amp;quot;consolidated&amp;quot; columns (preceded by the ID column). Thus, the ID&amp;#039;s were in column A while the consolidated fold changes for each biological replicate were in columns B through J. The average across the five untreated samples were calculated in column K (using the previously mentioned command), with the header &amp;quot;AVG_Biofilm_scaled_centered&amp;quot;. In column L, the same was done using the three treated samples.&lt;br /&gt;
# In column M, the ratios between the averages for treated and untreated samples were calculated. However, because these fold changes are in log space the fold changes for the treated samples were &amp;#039;&amp;#039;subtracted&amp;#039;&amp;#039; from that of the untreated samples. The header for this column was &amp;quot;Biofilm_Tobramycin_ratio&amp;quot;.&lt;br /&gt;
#* An example command for the gene in 2, is &amp;lt;code&amp;gt;=L2-K2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Next, the p-value&amp;#039;s for each fold change ratio was calculated in column M. A type-3, 2-tailed T-test was used.&lt;br /&gt;
#* The command for the first gene (row 2) is &amp;lt;code&amp;gt;=TTEST(C2:G2,H2:J2,2,3)&amp;lt;/code&amp;gt;. As before, this was pasted through all genes.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;bonferroni_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet were the gene ID&amp;#039;s (column A), the biofilm-tobramycin fold change ratios (column B) and the previously calculated P-values (column C). &lt;br /&gt;
# The header for column D was &amp;quot;bonferroni_p_value,&amp;quot; and in this column were the Bonferroni adjusted P-values. To calculate this value, each previous P-value was multiplied by 7,251 (the number of genes on the sheet). &lt;br /&gt;
#* For example, the command for the first gene (cell D2) was &amp;lt;code&amp;gt;=C2*7251&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Because this yields many P-values which are over 1 (which statistically speaking, should be impossible), a second &amp;quot;bonferroni_p_value&amp;quot; column was added next to the previous one (column E). In this column, P-values over 1 were replaced with a 1.&lt;br /&gt;
#* The command for cell E2 was &amp;lt;code&amp;gt;=IF(D2&amp;gt;1,1,D2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;BH_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. &lt;br /&gt;
# First, the same information pasted into the &amp;quot;bonferroni_p_value&amp;quot; sheet was pasted into this new sheet.&lt;br /&gt;
# A column was then inserted between columns A and B. The header for this new column (now column B), was &amp;quot;Master Index.&amp;quot; With the gene ID&amp;#039;s in numerical order, an ascending count was added to the Master Index column. This was done by adding values 1 and 2 to cells B2 and B3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the ascending count.&lt;br /&gt;
# A filter was then added to the P-value column (these are the unadjusted P-values, not the previously calculated Bonferroni-adjusted ones), and was used to sort this column in ascending order.&lt;br /&gt;
# After the genes (rows) were ordered by ascending P-value, they were ranked in column D (with the header &amp;quot;Rank&amp;quot;). This was done by adding values 1 and 2 to cells D2 and D3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the rank (an ascending count).&lt;br /&gt;
# In column E (with the header &amp;quot;BH_p_value&amp;quot;) the Benjamini-Hochberg adjusted P-values were calculated. This was done by multiplying each unadjusted P-value by its own rank.\&lt;br /&gt;
#* The command for row 2 was &amp;lt;code&amp;gt;=C2*D2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# As done for the Bonferroni adjustment, BH P-values which were over 1 were replaced with a 1 in column F (also with the header &amp;quot;BH_p_value&amp;quot;).&lt;br /&gt;
#* The command for row 2 was &amp;lt;code&amp;gt;=IF(E2&amp;gt;1,1,E2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The final sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;forGenMAPP&amp;#039;&amp;#039;&amp;#039;&amp;quot;. This included columns A-M of the &amp;quot;statistics&amp;quot; sheet (gene ID&amp;#039;s, consolidated fold change values, averages for treated and untreated samples, fold change ratios between treated and untreated samples, and corresponding P-values), pasted into those same columns. These were followed by the calculated Bonferroni and BH P-values in columns O and P respectively.&lt;br /&gt;
# All fold change values in the &amp;quot;forGenMAPP&amp;quot; sheet were formatted to include two decimals, while P-values were formatted to include four.&lt;br /&gt;
&lt;br /&gt;
The final spreadsheet is available [[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|here]].&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVP_Sanitycheck.png|center]]&lt;br /&gt;
* The criteria we chose for significance was &amp;#039;&amp;#039;&amp;#039;BH P-value &amp;gt; 0.05&amp;#039;&amp;#039;&amp;#039;. This results in 609 genes being considered significant, or 8.4% of the total genes. Obviously, most of Van Acker et al&amp;#039;s reportedly-significant genes (by unadjusted P-value &amp;gt; 0.05) were considered unsignificant by our criteria. However, we are confident in using the BH-adjusted P-value, as Van Acker et al&amp;#039;s unadjusted criteria considers 2688 genes (~31%) to be significant, and this is number is quite high. &lt;br /&gt;
* The difference in actual log fold change values may be alarming as well. However, the main point in our data processing protocol at which this log fold changes decreased so dramatically was in finding the ratios between fold changes for treated and untreated samples (which were actually subtracted, as the values are in log space), and we are confident that this step is necessary, as both treated and untreated samples were hybridized to the microarray slide against genomic DNA. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;There are 7251 genes in the sheet.&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
*How many genes have p value &amp;lt; 0.05? And what is the percentage?&lt;br /&gt;
** 4318, ~60%&lt;br /&gt;
*What about p &amp;lt; 0.01?&lt;br /&gt;
** 2971, ~41%&lt;br /&gt;
*What about p &amp;lt; 0.001? &lt;br /&gt;
** 1460, ~20%&lt;br /&gt;
*What about p &amp;lt; 0.0001?&lt;br /&gt;
** 645, ~9%&lt;br /&gt;
&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Bonferroni-corrected p value? &lt;br /&gt;
** 179, ~2.4%&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Benjamini and Hochberg-corrected p value? &lt;br /&gt;
** 609, ~8.4%&lt;br /&gt;
&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0. &lt;br /&gt;
** 2169, ~30%&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;lt; 0.&lt;br /&gt;
** 2149, ~30%&lt;br /&gt;
&lt;br /&gt;
This is a more realistic values for the fold change cut-offs because it represents about a 20% fold change which is about the level of detection of this technology:&lt;br /&gt;
*&amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05.&lt;br /&gt;
** 1488, ~21%&lt;br /&gt;
*&amp;quot;Biofilm_tobramycin_ratio&amp;quot; &amp;lt; -0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05. &lt;br /&gt;
** 2830, ~40%&lt;br /&gt;
&lt;br /&gt;
=== GenMAPP Import ===&lt;br /&gt;
&lt;br /&gt;
# With the &amp;quot;forGenMAPP&amp;quot; sheet open, the excel file was then saved as a Text Tab Delimited file.&lt;br /&gt;
# GenMAPP 2.1 was opened.&lt;br /&gt;
# The newly-created database was loaded into the program with &amp;quot;Data&amp;quot; &amp;gt; &amp;quot;Choose Gene Database&amp;quot;. This database is available [[Media:Bc-Std_GEN_20151204.zip|here]]. &lt;br /&gt;
# Next &amp;quot;Data&amp;quot; &amp;gt; &amp;quot;Expression Dataset Manager&amp;quot; was selected. &lt;br /&gt;
# In the Expression Dataset Manager window, &amp;quot;Expression Datasets&amp;quot; &amp;gt; &amp;quot;New Dataset&amp;quot; was selected, and the txt file from the &amp;quot;forGenMAPP&amp;quot; sheet was selected.&lt;br /&gt;
# Two criteria were created in the Expression Dataset Manager window for increases and decreases in expression.&lt;br /&gt;
#* &amp;#039;&amp;#039;Note: these criteria may have not been done correctly. Further analysis in GenMAPP will be conducted next week, and these criteria will be more closely examined. The main goal for this week is to generate the exceptions file (see below).&amp;#039;&amp;#039;&lt;br /&gt;
# GenMAPP processed the data and generated the following exceptions file, citing &amp;#039;&amp;#039;&amp;#039;284 errors&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* The exceptions file can be found [[media:For_genMAPP_KWVP20151205.EX.txt|here]].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7410</id>
		<title>Kevin Wyllie Week 14</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7410"/>
				<updated>2015-12-08T05:06:10Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added to the sanity check.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== Statistical Analysis and Formatting === &lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;We looked at Dr. Dahlquist&amp;#039;s comments on our prior worksheet to make a second attempt at processing and formatting for GenMAPP. Our biggest error in the the previous attempt was forgetting to account for the fact that each gene was spotted in (technical) quadruplicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Dr. Dahlquist prepared a sheet for us to start with, which separated each quadruplicate of the genome across columns. So the ID column for the first technical replicate was in column A, followed by fold change data for one of the four technical replicates within each of the biological replicates, for the (untreated) biofilm and tobramycin-treated biofilm samples. Next was the second ID column (identical to the first) in column J, followed by the second set of technical replicates within each biological replicate. These sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;quadruplicated_spots_separated&amp;#039;&amp;#039;&amp;#039;&amp;quot;.&lt;br /&gt;
# After all four sets of technical replicates, yet another ID column (column AK) was added, following by the averaged fold change values across each technical replicate (for each biological replicate - columns AL through AS). &lt;br /&gt;
#* For these averages the &amp;lt;code&amp;gt;=AVERAGE(*four technical replicates*)&amp;lt;/code&amp;gt; command was used and pasted through the entirety of each column. The *four technical replicates* is a placeholder for the cell coordinates corresponding to each technical replicate within a biological replicate.&lt;br /&gt;
#* Because all five untreated and all three treated samples will be averaged later in the protocol, the word &amp;quot;consolidated&amp;quot; (instead of &amp;quot;average&amp;quot;) was used in the headings for these columns. For example, the column heading for the first biological untreated sample was &amp;quot;consolidated_Biofilm_1_scaled_centered_4&amp;quot;.&lt;br /&gt;
# Next, a new sheet was created, named &amp;quot;&amp;#039;&amp;#039;&amp;#039;statistics&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet (using the &amp;quot;Paste Values&amp;quot; function) were the &amp;quot;consolidated&amp;quot; columns (preceded by the ID column). Thus, the ID&amp;#039;s were in column A while the consolidated fold changes for each biological replicate were in columns B through J. The average across the five untreated samples were calculated in column K (using the previously mentioned command), with the header &amp;quot;AVG_Biofilm_scaled_centered&amp;quot;. In column L, the same was done using the three treated samples.&lt;br /&gt;
# In column M, the ratios between the averages for treated and untreated samples were calculated. However, because these fold changes are in log space the fold changes for the treated samples were &amp;#039;&amp;#039;subtracted&amp;#039;&amp;#039; from that of the untreated samples. The header for this column was &amp;quot;Biofilm_Tobramycin_ratio&amp;quot;.&lt;br /&gt;
#* An example command for the gene in 2, is &amp;lt;code&amp;gt;=L2-K2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Next, the p-value&amp;#039;s for each fold change ratio was calculated in column M. A type-3, 2-tailed T-test was used.&lt;br /&gt;
#* The command for the first gene (row 2) is &amp;lt;code&amp;gt;=TTEST(C2:G2,H2:J2,2,3)&amp;lt;/code&amp;gt;. As before, this was pasted through all genes.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;bonferroni_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet were the gene ID&amp;#039;s (column A), the biofilm-tobramycin fold change ratios (column B) and the previously calculated P-values (column C). &lt;br /&gt;
# The header for column D was &amp;quot;bonferroni_p_value,&amp;quot; and in this column were the Bonferroni adjusted P-values. To calculate this value, each previous P-value was multiplied by 7,251 (the number of genes on the sheet). &lt;br /&gt;
#* For example, the command for the first gene (cell D2) was &amp;lt;code&amp;gt;=C2*7251&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Because this yields many P-values which are over 1 (which statistically speaking, should be impossible), a second &amp;quot;bonferroni_p_value&amp;quot; column was added next to the previous one (column E). In this column, P-values over 1 were replaced with a 1.&lt;br /&gt;
#* The command for cell E2 was &amp;lt;code&amp;gt;=IF(D2&amp;gt;1,1,D2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;BH_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. &lt;br /&gt;
# First, the same information pasted into the &amp;quot;bonferroni_p_value&amp;quot; sheet was pasted into this new sheet.&lt;br /&gt;
# A column was then inserted between columns A and B. The header for this new column (now column B), was &amp;quot;Master Index.&amp;quot; With the gene ID&amp;#039;s in numerical order, an ascending count was added to the Master Index column. This was done by adding values 1 and 2 to cells B2 and B3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the ascending count.&lt;br /&gt;
# A filter was then added to the P-value column (these are the unadjusted P-values, not the previously calculated Bonferroni-adjusted ones), and was used to sort this column in ascending order.&lt;br /&gt;
# After the genes (rows) were ordered by ascending P-value, they were ranked in column D (with the header &amp;quot;Rank&amp;quot;). This was done by adding values 1 and 2 to cells D2 and D3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the rank (an ascending count).&lt;br /&gt;
# In column E (with the header &amp;quot;BH_p_value&amp;quot;) the Benjamini-Hochberg adjusted P-values were calculated. This was done by multiplying each unadjusted P-value by its own rank.\&lt;br /&gt;
#* The command for row 2 was &amp;lt;code&amp;gt;=C2*D2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# As done for the Bonferroni adjustment, BH P-values which were over 1 were replaced with a 1 in column F (also with the header &amp;quot;BH_p_value&amp;quot;).&lt;br /&gt;
#* The command for row 2 was &amp;lt;code&amp;gt;=IF(E2&amp;gt;1,1,E2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The final sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;forGenMAPP&amp;#039;&amp;#039;&amp;#039;&amp;quot;. This included columns A-M of the &amp;quot;statistics&amp;quot; sheet (gene ID&amp;#039;s, consolidated fold change values, averages for treated and untreated samples, fold change ratios between treated and untreated samples, and corresponding P-values), pasted into those same columns. These were followed by the calculated Bonferroni and BH P-values in columns O and P respectively.&lt;br /&gt;
# All fold change values in the &amp;quot;forGenMAPP&amp;quot; sheet were formatted to include two decimals, while P-values were formatted to include four.&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
[[file:KWVP_Sanitycheck.png|center]]&lt;br /&gt;
* The criteria we chose for significance was &amp;#039;&amp;#039;&amp;#039;BH P-value &amp;gt; 0.05&amp;#039;&amp;#039;&amp;#039;. This results in 609 genes being considered significant, or 8.4% of the total genes. Obviously, most of Van Acker et al&amp;#039;s reportedly-significant genes (by unadjusted P-value &amp;gt; 0.05) were considered unsignificant by our criteria. However, we are confident in using the BH-adjusted P-value, as Van Acker et al&amp;#039;s unadjusted criteria considers 2688 genes (~31%) to be significant, and this is number is quite high. &lt;br /&gt;
* The difference in actual log fold change values may be alarming as well. However, the main point in our data processing protocol at which this log fold changes decreased so dramatically was in finding the ratios between fold changes for treated and untreated samples (which were actually subtracted, as the values are in log space), and we are confident that this step is necessary, as both treated and untreated samples were hybridized to the microarray slide against genomic DNA. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;There are 7251 genes in the sheet.&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
*How many genes have p value &amp;lt; 0.05? And what is the percentage?&lt;br /&gt;
** 4318, ~60%&lt;br /&gt;
*What about p &amp;lt; 0.01?&lt;br /&gt;
** 2971, ~41%&lt;br /&gt;
*What about p &amp;lt; 0.001? &lt;br /&gt;
** 1460, ~20%&lt;br /&gt;
*What about p &amp;lt; 0.0001?&lt;br /&gt;
** 645, ~9%&lt;br /&gt;
&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Bonferroni-corrected p value? &lt;br /&gt;
** 179, ~2.4%&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Benjamini and Hochberg-corrected p value? &lt;br /&gt;
** 609, ~8.4%&lt;br /&gt;
&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0. &lt;br /&gt;
** 2169, ~30%&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;lt; 0.&lt;br /&gt;
** 2149, ~30%&lt;br /&gt;
&lt;br /&gt;
This is a more realistic values for the fold change cut-offs because it represents about a 20% fold change which is about the level of detection of this technology:&lt;br /&gt;
*&amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05.&lt;br /&gt;
** 1488, ~21%&lt;br /&gt;
*&amp;quot;Biofilm_tobramycin_ratio&amp;quot; &amp;lt; -0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05. &lt;br /&gt;
** 2830, ~40%&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP_Sanitycheck.png&amp;diff=7409</id>
		<title>File:KWVP Sanitycheck.png</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:KWVP_Sanitycheck.png&amp;diff=7409"/>
				<updated>2015-12-08T04:52:45Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: A table of our calculated fold changes versus those published by the authors - for genes of interest.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;A table of our calculated fold changes versus those published by the authors - for genes of interest.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7408</id>
		<title>Kevin Wyllie Week 14</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7408"/>
				<updated>2015-12-08T04:51:27Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Formatting edit.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== Statistical Analysis and Formatting === &lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;We looked at Dr. Dahlquist&amp;#039;s comments on our prior worksheet to make a second attempt at processing and formatting for GenMAPP. Our biggest error in the the previous attempt was forgetting to account for the fact that each gene was spotted in (technical) quadruplicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Dr. Dahlquist prepared a sheet for us to start with, which separated each quadruplicate of the genome across columns. So the ID column for the first technical replicate was in column A, followed by fold change data for one of the four technical replicates within each of the biological replicates, for the (untreated) biofilm and tobramycin-treated biofilm samples. Next was the second ID column (identical to the first) in column J, followed by the second set of technical replicates within each biological replicate. These sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;quadruplicated_spots_separated&amp;#039;&amp;#039;&amp;#039;&amp;quot;.&lt;br /&gt;
# After all four sets of technical replicates, yet another ID column (column AK) was added, following by the averaged fold change values across each technical replicate (for each biological replicate - columns AL through AS). &lt;br /&gt;
#* For these averages the &amp;lt;code&amp;gt;=AVERAGE(*four technical replicates*)&amp;lt;/code&amp;gt; command was used and pasted through the entirety of each column. The *four technical replicates* is a placeholder for the cell coordinates corresponding to each technical replicate within a biological replicate.&lt;br /&gt;
#* Because all five untreated and all three treated samples will be averaged later in the protocol, the word &amp;quot;consolidated&amp;quot; (instead of &amp;quot;average&amp;quot;) was used in the headings for these columns. For example, the column heading for the first biological untreated sample was &amp;quot;consolidated_Biofilm_1_scaled_centered_4&amp;quot;.&lt;br /&gt;
# Next, a new sheet was created, named &amp;quot;&amp;#039;&amp;#039;&amp;#039;statistics&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet (using the &amp;quot;Paste Values&amp;quot; function) were the &amp;quot;consolidated&amp;quot; columns (preceded by the ID column). Thus, the ID&amp;#039;s were in column A while the consolidated fold changes for each biological replicate were in columns B through J. The average across the five untreated samples were calculated in column K (using the previously mentioned command), with the header &amp;quot;AVG_Biofilm_scaled_centered&amp;quot;. In column L, the same was done using the three treated samples.&lt;br /&gt;
# In column M, the ratios between the averages for treated and untreated samples were calculated. However, because these fold changes are in log space the fold changes for the treated samples were &amp;#039;&amp;#039;subtracted&amp;#039;&amp;#039; from that of the untreated samples. The header for this column was &amp;quot;Biofilm_Tobramycin_ratio&amp;quot;.&lt;br /&gt;
#* An example command for the gene in 2, is &amp;lt;code&amp;gt;=L2-K2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Next, the p-value&amp;#039;s for each fold change ratio was calculated in column M. A type-3, 2-tailed T-test was used.&lt;br /&gt;
#* The command for the first gene (row 2) is &amp;lt;code&amp;gt;=TTEST(C2:G2,H2:J2,2,3)&amp;lt;/code&amp;gt;. As before, this was pasted through all genes.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;bonferroni_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet were the gene ID&amp;#039;s (column A), the biofilm-tobramycin fold change ratios (column B) and the previously calculated P-values (column C). &lt;br /&gt;
# The header for column D was &amp;quot;bonferroni_p_value,&amp;quot; and in this column were the Bonferroni adjusted P-values. To calculate this value, each previous P-value was multiplied by 7,251 (the number of genes on the sheet). &lt;br /&gt;
#* For example, the command for the first gene (cell D2) was &amp;lt;code&amp;gt;=C2*7251&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Because this yields many P-values which are over 1 (which statistically speaking, should be impossible), a second &amp;quot;bonferroni_p_value&amp;quot; column was added next to the previous one (column E). In this column, P-values over 1 were replaced with a 1.&lt;br /&gt;
#* The command for cell E2 was &amp;lt;code&amp;gt;=IF(D2&amp;gt;1,1,D2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;BH_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. &lt;br /&gt;
# First, the same information pasted into the &amp;quot;bonferroni_p_value&amp;quot; sheet was pasted into this new sheet.&lt;br /&gt;
# A column was then inserted between columns A and B. The header for this new column (now column B), was &amp;quot;Master Index.&amp;quot; With the gene ID&amp;#039;s in numerical order, an ascending count was added to the Master Index column. This was done by adding values 1 and 2 to cells B2 and B3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the ascending count.&lt;br /&gt;
# A filter was then added to the P-value column (these are the unadjusted P-values, not the previously calculated Bonferroni-adjusted ones), and was used to sort this column in ascending order.&lt;br /&gt;
# After the genes (rows) were ordered by ascending P-value, they were ranked in column D (with the header &amp;quot;Rank&amp;quot;). This was done by adding values 1 and 2 to cells D2 and D3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the rank (an ascending count).&lt;br /&gt;
# In column E (with the header &amp;quot;BH_p_value&amp;quot;) the Benjamini-Hochberg adjusted P-values were calculated. This was done by multiplying each unadjusted P-value by its own rank.\&lt;br /&gt;
#* The command for row 2 was &amp;lt;code&amp;gt;=C2*D2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# As done for the Bonferroni adjustment, BH P-values which were over 1 were replaced with a 1 in column F (also with the header &amp;quot;BH_p_value&amp;quot;).&lt;br /&gt;
#* The command for row 2 was &amp;lt;code&amp;gt;=IF(E2&amp;gt;1,1,E2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The final sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;forGenMAPP&amp;#039;&amp;#039;&amp;#039;&amp;quot;. This included columns A-M of the &amp;quot;statistics&amp;quot; sheet (gene ID&amp;#039;s, consolidated fold change values, averages for treated and untreated samples, fold change ratios between treated and untreated samples, and corresponding P-values), pasted into those same columns. These were followed by the calculated Bonferroni and BH P-values in columns O and P respectively.&lt;br /&gt;
# All fold change values in the &amp;quot;forGenMAPP&amp;quot; sheet were formatted to include two decimals, while P-values were formatted to include four.&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;There are 7251 genes in the sheet.&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
*How many genes have p value &amp;lt; 0.05? And what is the percentage?&lt;br /&gt;
** 4318, ~60%&lt;br /&gt;
*What about p &amp;lt; 0.01?&lt;br /&gt;
** 2971, ~41%&lt;br /&gt;
*What about p &amp;lt; 0.001? &lt;br /&gt;
** 1460, ~20%&lt;br /&gt;
*What about p &amp;lt; 0.0001?&lt;br /&gt;
** 645, ~9%&lt;br /&gt;
&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Bonferroni-corrected p value? &lt;br /&gt;
** 179, ~2.4%&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Benjamini and Hochberg-corrected p value? &lt;br /&gt;
** 609, ~8.4%&lt;br /&gt;
&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0. &lt;br /&gt;
** 2169, ~30%&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;lt; 0.&lt;br /&gt;
** 2149, ~30%&lt;br /&gt;
&lt;br /&gt;
This is a more realistic values for the fold change cut-offs because it represents about a 20% fold change which is about the level of detection of this technology:&lt;br /&gt;
*&amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05.&lt;br /&gt;
** 1488, ~21%&lt;br /&gt;
*&amp;quot;Biofilm_tobramycin_ratio&amp;quot; &amp;lt; -0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05. &lt;br /&gt;
** 2830, ~40%&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7398</id>
		<title>Kevin Wyllie Week 14</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7398"/>
				<updated>2015-12-08T04:05:06Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added to sanity check.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== Statistical Analysis and Formatting === &lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;We looked at Dr. Dahlquist&amp;#039;s comments on our prior worksheet to make a second attempt at processing and formatting for GenMAPP. Our biggest error in the the previous attempt was forgetting to account for the fact that each gene was spotted in (technical) quadruplicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Dr. Dahlquist prepared a sheet for us to start with, which separated each quadruplicate of the genome across columns. So the ID column for the first technical replicate was in column A, followed by fold change data for one of the four technical replicates within each of the biological replicates, for the (untreated) biofilm and tobramycin-treated biofilm samples. Next was the second ID column (identical to the first) in column J, followed by the second set of technical replicates within each biological replicate. These sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;quadruplicated_spots_separated&amp;#039;&amp;#039;&amp;#039;&amp;quot;.&lt;br /&gt;
# After all four sets of technical replicates, yet another ID column (column AK) was added, following by the averaged fold change values across each technical replicate (for each biological replicate - columns AL through AS). &lt;br /&gt;
#* For these averages the &amp;lt;code&amp;gt;=AVERAGE(*four technical replicates*)&amp;lt;/code&amp;gt; command was used and pasted through the entirety of each column. The *four technical replicates* is a placeholder for the cell coordinates corresponding to each technical replicate within a biological replicate.&lt;br /&gt;
#* Because all five untreated and all three treated samples will be averaged later in the protocol, the word &amp;quot;consolidated&amp;quot; (instead of &amp;quot;average&amp;quot;) was used in the headings for these columns. For example, the column heading for the first biological untreated sample was &amp;quot;consolidated_Biofilm_1_scaled_centered_4&amp;quot;.&lt;br /&gt;
# Next, a new sheet was created, named &amp;quot;&amp;#039;&amp;#039;&amp;#039;statistics&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet (using the &amp;quot;Paste Values&amp;quot; function) were the &amp;quot;consolidated&amp;quot; columns (preceded by the ID column). Thus, the ID&amp;#039;s were in column A while the consolidated fold changes for each biological replicate were in columns B through J. The average across the five untreated samples were calculated in column K (using the previously mentioned command), with the header &amp;quot;AVG_Biofilm_scaled_centered&amp;quot;. In column L, the same was done using the three treated samples.&lt;br /&gt;
# In column M, the ratios between the averages for treated and untreated samples were calculated. However, because these fold changes are in log space the fold changes for the treated samples were &amp;#039;&amp;#039;subtracted&amp;#039;&amp;#039; from that of the untreated samples. The header for this column was &amp;quot;Biofilm_Tobramycin_ratio&amp;quot;.&lt;br /&gt;
#* An example command for the gene in 2, is &amp;lt;code&amp;gt;=L2-K2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Next, the p-value&amp;#039;s for each fold change ratio was calculated in column M. A type-3, 2-tailed T-test was used.&lt;br /&gt;
#* The command for the first gene (row 2) is &amp;lt;code&amp;gt;=TTEST(C2:G2,H2:J2,2,3)&amp;lt;/code&amp;gt;. As before, this was pasted through all genes.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;bonferroni_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet were the gene ID&amp;#039;s (column A), the biofilm-tobramycin fold change ratios (column B) and the previously calculated P-values (column C). &lt;br /&gt;
# The header for column D was &amp;quot;bonferroni_p_value,&amp;quot; and in this column were the Bonferroni adjusted P-values. To calculate this value, each previous P-value was multiplied by 7,251 (the number of genes on the sheet). &lt;br /&gt;
#* For example, the command for the first gene (cell D2) was &amp;lt;code&amp;gt;=C2*7251&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Because this yields many P-values which are over 1 (which statistically speaking, should be impossible), a second &amp;quot;bonferroni_p_value&amp;quot; column was added next to the previous one (column E). In this column, P-values over 1 were replaced with a 1.&lt;br /&gt;
#* The command for cell E2 was &amp;lt;code&amp;gt;=IF(D2&amp;gt;1,1,D2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;BH_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. &lt;br /&gt;
# First, the same information pasted into the &amp;quot;bonferroni_p_value&amp;quot; sheet was pasted into this new sheet.&lt;br /&gt;
# A column was then inserted between columns A and B. The header for this new column (now column B), was &amp;quot;Master Index.&amp;quot; With the gene ID&amp;#039;s in numerical order, an ascending count was added to the Master Index column. This was done by adding values 1 and 2 to cells B2 and B3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the ascending count.&lt;br /&gt;
# A filter was then added to the P-value column (these are the unadjusted P-values, not the previously calculated Bonferroni-adjusted ones), and was used to sort this column in ascending order.&lt;br /&gt;
# After the genes (rows) were ordered by ascending P-value, they were ranked in column D (with the header &amp;quot;Rank&amp;quot;). This was done by adding values 1 and 2 to cells D2 and D3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the rank (an ascending count).&lt;br /&gt;
# In column E (with the header &amp;quot;BH_p_value&amp;quot;) the Benjamini-Hochberg adjusted P-values were calculated. This was done by multiplying each unadjusted P-value by its own rank.\&lt;br /&gt;
#* The command for row 2 was &amp;lt;code&amp;gt;=C2*D2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# As done for the Bonferroni adjustment, BH P-values which were over 1 were replaced with a 1 in column F (also with the header &amp;quot;BH_p_value&amp;quot;).&lt;br /&gt;
#* The command for row 2 was &amp;lt;code&amp;gt;=IF(E2&amp;gt;1,1,E2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The final sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;forGenMAPP&amp;#039;&amp;#039;&amp;#039;&amp;quot;. This included columns A-M of the &amp;quot;statistics&amp;quot; sheet (gene ID&amp;#039;s, consolidated fold change values, averages for treated and untreated samples, fold change ratios between treated and untreated samples, and corresponding P-values), pasted into those same columns. These were followed by the calculated Bonferroni and BH P-values in columns O and P respectively.&lt;br /&gt;
# All fold change values in the &amp;quot;&amp;#039;&amp;#039;&amp;#039;forGenMAPP&amp;#039;&amp;#039;&amp;#039;&amp;quot; sheet were formatted to include two decimals, while P-values were formatted to include four.&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;There are 7251 genes in the sheet.&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
*How many genes have p value &amp;lt; 0.05? And what is the percentage?&lt;br /&gt;
** 4318, ~60%&lt;br /&gt;
*What about p &amp;lt; 0.01?&lt;br /&gt;
** 2971, ~41%&lt;br /&gt;
*What about p &amp;lt; 0.001? &lt;br /&gt;
** 1460, ~20%&lt;br /&gt;
*What about p &amp;lt; 0.0001?&lt;br /&gt;
** 645, ~9%&lt;br /&gt;
&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Bonferroni-corrected p value? &lt;br /&gt;
** 179, ~2.4%&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Benjamini and Hochberg-corrected p value? &lt;br /&gt;
** 609, ~8.4%&lt;br /&gt;
&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0. &lt;br /&gt;
** 2169, ~30%&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;lt; 0.&lt;br /&gt;
** 2149, ~30%&lt;br /&gt;
&lt;br /&gt;
This is a more realistic values for the fold change cut-offs because it represents about a 20% fold change which is about the level of detection of this technology:&lt;br /&gt;
*&amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05.&lt;br /&gt;
** 1488, ~21%&lt;br /&gt;
*&amp;quot;Biofilm_tobramycin_ratio&amp;quot; &amp;lt; -0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05. &lt;br /&gt;
** 2830, ~40%&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7392</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7392"/>
				<updated>2015-12-08T03:57:56Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added a file to our weekly progress report section.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
*Further explore the various ID systems; verify previous findings&lt;br /&gt;
*Create expressions for Match/PGSQL that will assist in evaluating the quality of any exported databases&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Completed Milestone 1: Initial Database Export&lt;br /&gt;
*Completed Milestone 2: ID Pattern Definition and Verification (will be revisited for future work with modified forms of GenMAPP builder) &lt;br /&gt;
**Should talk to Anu about further steps involving TallyEngine/GenMAPP builder (organize more exports)&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:WEEK12FILES GEN BL.zip|Week 12 Files]]&lt;br /&gt;
*[[Media:ORIG GEN BL12.zip|Starting Files]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Week 14=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finish second build.&lt;br /&gt;
* Analyze results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Begin modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Start writing README and scientific paper (parts of deliverables).&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Perform database export on the second build and other builds of the customized genMAPP builder&lt;br /&gt;
* Determine, with Anu, what modifications must be done to GenMAPP builder/Tallyengine&lt;br /&gt;
* Find out why most of the data/gene-names were not captured in the &amp;quot;OrderedLocusNames&amp;quot; table of the PSQL database for Export 1&lt;br /&gt;
* Perform testing report on any builds created for the week.&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finished second build. &lt;br /&gt;
* Analyzed results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Began modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Finished third build.&lt;br /&gt;
* Customized Tally Engine to collect counts for ORF ID&amp;#039;s.&lt;br /&gt;
* Finished fourth build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Performed the statistical analysis in Excel.&lt;br /&gt;
*Formatted the gene expression data for import into GenMAPP.&lt;br /&gt;
*Imported data into GenMAPP, created ColorSets, and ran MAPPFinder.&lt;br /&gt;
*Documented and took screenshots on test runs with GenMAPP.&lt;br /&gt;
*Sent the EX.txt file to Brandon and also uploaded on wiki&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 14]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 14]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 14]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 14]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
Build 2 - with customized species profile:&lt;br /&gt;
* [[Media: Gmbuilder-genialomics-12012015-build-2.zip| gmbuilder-genialomics-12012015-build-2.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:22, 1 December 2015 (PST) &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 3 - picking up gene names from ORF instead of ordered locus&lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-3.zip | gmbuilder-genialomics-12032015-build-3.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 14:58, 3 December 2015 (PST)&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 4 - customized TallyEngine &lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-4.zip|gmbuilder-genialomics-12032015-build-4.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:18, 3 December 2015 (PST)&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:Bc-Std_GEN_20151204.zip|Compressed gdb from Build 4]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt; see Kevin&amp;#039;s section --&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; [[media:Raw_compiled_data_FINAL_KWVP20151507.xlsx|Final processed/formatted microarray data spreadsheet]]&lt;br /&gt;
[[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file from first export.]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Deliverables=&lt;br /&gt;
=== Group Deliverables ===&lt;br /&gt;
&lt;br /&gt;
* GenMAPP Gene Database for assigned species (&amp;#039;&amp;#039;.gdb&amp;#039;&amp;#039;)&lt;br /&gt;
* ReadMe file to accompany the Gene Database (&amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
** Sample ReadMe in Word format:  [[Media:ReadMe_Vc-Std_External_20131122.zip | ReadMe_Vc-Std_External_20131122.zip]]&lt;br /&gt;
** [https://github.com/lmu-bioinformatics/xmlpipedb/blob/readme/GenMAPP%20Gene%20Databases/V.%20cholerae/V.%20cholerae%2020101022/ReadMe.md Sample ReadMe in markdown (a work in progress)] &lt;br /&gt;
** Include Gene Database Schema diagram in ReadMe&lt;br /&gt;
*** Sample schema in Adobe Illustrator format:  [[Media:Vibrio_schema_20101022.zip | Vibrio_schema_20101022.zip]]&lt;br /&gt;
* Gene Database Testing Report for final submitted Gene Database (print from wiki to &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039; file)&lt;br /&gt;
* Processed and analyzed DNA microarray dataset (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Data file used for import into GenMAPP (&amp;#039;&amp;#039;.txt&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.csv&amp;#039;&amp;#039;)&lt;br /&gt;
* GenMAPP Expression Dataset file (&amp;#039;&amp;#039;.gex&amp;#039;&amp;#039;)&lt;br /&gt;
* Exceptions file of data imported into GenMAPP (&amp;#039;&amp;#039;.EX.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* Raw MAPPFinder results files (&amp;#039;&amp;#039;-GO.txt&amp;#039;&amp;#039;)&lt;br /&gt;
* &amp;#039;&amp;#039;.gmf&amp;#039;&amp;#039; file&lt;br /&gt;
* Filtered MAPPFinder Results (&amp;#039;&amp;#039;.xls&amp;#039;&amp;#039; or &amp;#039;&amp;#039;.xlsx&amp;#039;&amp;#039;)&lt;br /&gt;
* Sample MAPP file of a relevant biological pathway for your species (&amp;#039;&amp;#039;.mapp&amp;#039;&amp;#039;)&lt;br /&gt;
* [[Gene Database Project Deliverables#Group Report | Group Report]] describing the creation of the Gene Database and the biological analysis of the data (&amp;#039;&amp;#039;.doc&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.docx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;)&lt;br /&gt;
* PowerPoint presentation (&amp;#039;&amp;#039;.ppt&amp;#039;&amp;#039;, &amp;#039;&amp;#039;.pptx&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;.pdf&amp;#039;&amp;#039;, given on Tuesday, December 15)&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:Raw_compiled_data_FINAL_KWVP20151507.xlsx&amp;diff=7391</id>
		<title>File:Raw compiled data FINAL KWVP20151507.xlsx</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:Raw_compiled_data_FINAL_KWVP20151507.xlsx&amp;diff=7391"/>
				<updated>2015-12-08T03:56:35Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Our final expression dataset file, including the &amp;quot;forGenMAPP&amp;quot; sheet.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Our final expression dataset file, including the &amp;quot;forGenMAPP&amp;quot; sheet.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7388</id>
		<title>Kevin Wyllie Week 14</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7388"/>
				<updated>2015-12-08T03:53:00Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Finished protocol for data processing/formatting.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== Statistical Analysis and Formatting === &lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;We looked at Dr. Dahlquist&amp;#039;s comments on our prior worksheet to make a second attempt at processing and formatting for GenMAPP. Our biggest error in the the previous attempt was forgetting to account for the fact that each gene was spotted in (technical) quadruplicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Dr. Dahlquist prepared a sheet for us to start with, which separated each quadruplicate of the genome across columns. So the ID column for the first technical replicate was in column A, followed by fold change data for one of the four technical replicates within each of the biological replicates, for the (untreated) biofilm and tobramycin-treated biofilm samples. Next was the second ID column (identical to the first) in column J, followed by the second set of technical replicates within each biological replicate. These sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;quadruplicated_spots_separated&amp;#039;&amp;#039;&amp;#039;&amp;quot;.&lt;br /&gt;
# After all four sets of technical replicates, yet another ID column (column AK) was added, following by the averaged fold change values across each technical replicate (for each biological replicate - columns AL through AS). &lt;br /&gt;
#* For these averages the &amp;lt;code&amp;gt;=AVERAGE(*four technical replicates*)&amp;lt;/code&amp;gt; command was used and pasted through the entirety of each column. The *four technical replicates* is a placeholder for the cell coordinates corresponding to each technical replicate within a biological replicate.&lt;br /&gt;
#* Because all five untreated and all three treated samples will be averaged later in the protocol, the word &amp;quot;consolidated&amp;quot; (instead of &amp;quot;average&amp;quot;) was used in the headings for these columns. For example, the column heading for the first biological untreated sample was &amp;quot;consolidated_Biofilm_1_scaled_centered_4&amp;quot;.&lt;br /&gt;
# Next, a new sheet was created, named &amp;quot;&amp;#039;&amp;#039;&amp;#039;statistics&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet (using the &amp;quot;Paste Values&amp;quot; function) were the &amp;quot;consolidated&amp;quot; columns (preceded by the ID column). Thus, the ID&amp;#039;s were in column A while the consolidated fold changes for each biological replicate were in columns B through J. The average across the five untreated samples were calculated in column K (using the previously mentioned command), with the header &amp;quot;AVG_Biofilm_scaled_centered&amp;quot;. In column L, the same was done using the three treated samples.&lt;br /&gt;
# In column M, the ratios between the averages for treated and untreated samples were calculated. However, because these fold changes are in log space the fold changes for the treated samples were &amp;#039;&amp;#039;subtracted&amp;#039;&amp;#039; from that of the untreated samples. The header for this column was &amp;quot;Biofilm_Tobramycin_ratio&amp;quot;.&lt;br /&gt;
#* An example command for the gene in 2, is &amp;lt;code&amp;gt;=L2-K2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Next, the p-value&amp;#039;s for each fold change ratio was calculated in column M. A type-3, 2-tailed T-test was used.&lt;br /&gt;
#* The command for the first gene (row 2) is &amp;lt;code&amp;gt;=TTEST(C2:G2,H2:J2,2,3)&amp;lt;/code&amp;gt;. As before, this was pasted through all genes.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;bonferroni_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet were the gene ID&amp;#039;s (column A), the biofilm-tobramycin fold change ratios (column B) and the previously calculated P-values (column C). &lt;br /&gt;
# The header for column D was &amp;quot;bonferroni_p_value,&amp;quot; and in this column were the Bonferroni adjusted P-values. To calculate this value, each previous P-value was multiplied by 7,251 (the number of genes on the sheet). &lt;br /&gt;
#* For example, the command for the first gene (cell D2) was &amp;lt;code&amp;gt;=C2*7251&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Because this yields many P-values which are over 1 (which statistically speaking, should be impossible), a second &amp;quot;bonferroni_p_value&amp;quot; column was added next to the previous one (column E). In this column, P-values over 1 were replaced with a 1.&lt;br /&gt;
#* The command for cell E2 was &amp;lt;code&amp;gt;=IF(D2&amp;gt;1,1,D2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;BH_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. &lt;br /&gt;
# First, the same information pasted into the &amp;quot;bonferroni_p_value&amp;quot; sheet was pasted into this new sheet.&lt;br /&gt;
# A column was then inserted between columns A and B. The header for this new column (now column B), was &amp;quot;Master Index.&amp;quot; With the gene ID&amp;#039;s in numerical order, an ascending count was added to the Master Index column. This was done by adding values 1 and 2 to cells B2 and B3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the ascending count.&lt;br /&gt;
# A filter was then added to the P-value column (these are the unadjusted P-values, not the previously calculated Bonferroni-adjusted ones), and was used to sort this column in ascending order.&lt;br /&gt;
# After the genes (rows) were ordered by ascending P-value, they were ranked in column D (with the header &amp;quot;Rank&amp;quot;). This was done by adding values 1 and 2 to cells D2 and D3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the rank (an ascending count).&lt;br /&gt;
# In column E (with the header &amp;quot;BH_p_value&amp;quot;) the Benjamini-Hochberg adjusted P-values were calculated. This was done by multiplying each unadjusted P-value by its own rank.\&lt;br /&gt;
#* The command for row 2 was &amp;lt;code&amp;gt;=C2*D2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# As done for the Bonferroni adjustment, BH P-values which were over 1 were replaced with a 1 in column F (also with the header &amp;quot;BH_p_value&amp;quot;).&lt;br /&gt;
#* The command for row 2 was &amp;lt;code&amp;gt;=IF(E2&amp;gt;1,1,E2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The final sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;forGenMAPP&amp;#039;&amp;#039;&amp;#039;&amp;quot;. This included columns A-M of the &amp;quot;statistics&amp;quot; sheet (gene ID&amp;#039;s, consolidated fold change values, averages for treated and untreated samples, fold change ratios between treated and untreated samples, and corresponding P-values), pasted into those same columns. These were followed by the calculated Bonferroni and BH P-values in columns O and P respectively.&lt;br /&gt;
# All fold change values in the &amp;quot;&amp;#039;&amp;#039;&amp;#039;forGenMAPP&amp;#039;&amp;#039;&amp;#039;&amp;quot; sheet were formatted to include two decimals, while P-values were formatted to include four.&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;There are 7251 genes in the sheet.&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
*How many genes have p value &amp;lt; 0.05? And what is the percentage?&lt;br /&gt;
** 4318, ~60%&lt;br /&gt;
*What about p &amp;lt; 0.01?&lt;br /&gt;
** 2971, ~41%&lt;br /&gt;
*What about p &amp;lt; 0.001? &lt;br /&gt;
** 1460, ~20%&lt;br /&gt;
*What about p &amp;lt; 0.0001?&lt;br /&gt;
** 645, ~9%&lt;br /&gt;
&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Bonferroni-corrected p value? &lt;br /&gt;
** 179, ~2.4%&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Benjamini and Hochberg-corrected p value? &lt;br /&gt;
** 609, ~8.4%&lt;br /&gt;
&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0. &lt;br /&gt;
** &lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.&lt;br /&gt;
**&lt;br /&gt;
&lt;br /&gt;
This is a more realistic values for the fold change cut-offs because it represents about a 20% fold change which is about the level of detection of this technology:&lt;br /&gt;
*&amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05.&lt;br /&gt;
**&lt;br /&gt;
*&amp;quot;Biofilm_tobramycin_ratio&amp;quot; &amp;lt; -0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05. &lt;br /&gt;
**&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7349</id>
		<title>Kevin Wyllie Week 14</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7349"/>
				<updated>2015-12-07T19:58:09Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added more protocol.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== Statistical Analysis and Formatting === &lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;We looked at Dr. Dahlquist&amp;#039;s comments on our prior worksheet to make a second attempt at processing and formatting for GenMAPP. Our biggest error in the the previous attempt was forgetting to account for the fact that each gene was spotted in (technical) quadruplicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Dr. Dahlquist prepared a sheet for us to start with, which separated each quadruplicate of the genome across columns. So the ID column for the first technical replicate was in column A, followed by fold change data for one of the four technical replicates within each of the biological replicates, for the (untreated) biofilm and tobramycin-treated biofilm samples. Next was the second ID column (identical to the first) in column J, followed by the second set of technical replicates within each biological replicate. These sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;quadruplicated_spots_separated&amp;#039;&amp;#039;&amp;#039;&amp;quot;.&lt;br /&gt;
# After all four sets of technical replicates, yet another ID column (column AK) was added, following by the averaged fold change values across each technical replicate (for each biological replicate - columns AL through AS). &lt;br /&gt;
#* For these averages the &amp;lt;code&amp;gt;=AVERAGE(*four technical replicates*)&amp;lt;/code&amp;gt; command was used and pasted through the entirety of each column. The *four technical replicates* is a placeholder for the cell coordinates corresponding to each technical replicate within a biological replicate.&lt;br /&gt;
#* Because all five untreated and all three treated samples will be averaged later in the protocol, the word &amp;quot;consolidated&amp;quot; (instead of &amp;quot;average&amp;quot;) was used in the headings for these columns. For example, the column heading for the first biological untreated sample was &amp;quot;consolidated_Biofilm_1_scaled_centered_4&amp;quot;.&lt;br /&gt;
# Next, a new sheet was created, named &amp;quot;&amp;#039;&amp;#039;&amp;#039;statistics&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet (using the &amp;quot;Paste Values&amp;quot; function) were the &amp;quot;consolidated&amp;quot; columns (preceded by the ID column). Thus, the ID&amp;#039;s were in column A while the consolidated fold changes for each biological replicate were in columns B through J. The average across the five untreated samples were calculated in column K (using the previously mentioned command), with the header &amp;quot;AVG_Biofilm_scaled_centered&amp;quot;. In column L, the same was done using the three treated samples.&lt;br /&gt;
# In column M, the ratios between the averages for treated and untreated samples were calculated. However, because these fold changes are in log space the fold changes for the treated samples were &amp;#039;&amp;#039;subtracted&amp;#039;&amp;#039; from that of the untreated samples. The header for this column was &amp;quot;Biofilm_Tobramycin_ratio&amp;quot;.&lt;br /&gt;
#* An example command for the gene in 2, is &amp;lt;code&amp;gt;=L2-K2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Next, the p-value&amp;#039;s for each fold change ratio was calculated in column M. A type-3, 2-tailed T-test was used.&lt;br /&gt;
#* The command for the first gene (row 2) is &amp;lt;code&amp;gt;=TTEST(C2:G2,H2:J2,2,3)&amp;lt;/code&amp;gt;. As before, this was pasted through all genes.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;bonferroni_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet were the gene ID&amp;#039;s (column A), the biofilm-tobramycin fold change ratios (column B) and the previously calculated P-values (column C). &lt;br /&gt;
# The header for column D was &amp;quot;bonferroni_p_value,&amp;quot; and in this column were the Bonferroni adjusted P-values. To calculate this value, each previous P-value was multiplied by 7,251 (the number of genes on the sheet). &lt;br /&gt;
#* For example, the command for the first gene (cell D2) was &amp;lt;code&amp;gt;=C2*7251&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Because this yields many P-values which are over 1 (which statistically speaking, should be impossible), a second &amp;quot;bonferroni_p_value&amp;quot; column was added next to the previous one (column E). In this column, P-values over 1 were replaced with a 1.&lt;br /&gt;
#* The command for cell E2 was &amp;lt;code&amp;gt;=IF(D2&amp;gt;1,1,D2)&amp;lt;/code&amp;gt;.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;BH_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;. &lt;br /&gt;
# First, the same information pasted into the &amp;quot;bonferroni_p_value&amp;quot; sheet was pasted into this new sheet.&lt;br /&gt;
# A column was then inserted between columns A and B. The header for this new column (now column B), was &amp;quot;Master Index.&amp;quot; With the gene ID&amp;#039;s in numerical order, an ascending count was added to the Master Index column. This was done by adding values 1 and 2 to cells B2 and B3 respectively, highlighting these two cells, and right-clicking on the black square at the bottom-right of the highlighted region. This will automatically fill in the ascending count.&lt;br /&gt;
# A filter was then added to the P-value column (these are the unadjusted P-values, not the previously calculated Bonferroni-adjusted ones), and was used to sort this column in ascending order.&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;There are 7251 genes in the sheet.&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
*How many genes have p value &amp;lt; 0.05? And what is the percentage?&lt;br /&gt;
** 4318, ~60%&lt;br /&gt;
*What about p &amp;lt; 0.01?&lt;br /&gt;
** 2971, ~41%&lt;br /&gt;
*What about p &amp;lt; 0.001? &lt;br /&gt;
** 1460, ~20%&lt;br /&gt;
*What about p &amp;lt; 0.0001?&lt;br /&gt;
** 645, ~9%&lt;br /&gt;
&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Bonferroni-corrected p value? &lt;br /&gt;
** 179, ~2.4%&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Benjamini and Hochberg-corrected p value? &lt;br /&gt;
** 609, ~8.4%&lt;br /&gt;
&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0. &lt;br /&gt;
** &lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.&lt;br /&gt;
**&lt;br /&gt;
&lt;br /&gt;
This is a more realistic values for the fold change cut-offs because it represents about a 20% fold change which is about the level of detection of this technology:&lt;br /&gt;
*&amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05.&lt;br /&gt;
**&lt;br /&gt;
*&amp;quot;Biofilm_tobramycin_ratio&amp;quot; &amp;lt; -0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05. &lt;br /&gt;
**&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7338</id>
		<title>Kevin Wyllie Week 14</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7338"/>
				<updated>2015-12-07T05:37:54Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added my good practice links.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== Statistical Analysis and Formatting === &lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;We looked at Dr. Dahlquist&amp;#039;s comments on our prior worksheet to make a second attempt at processing and formatting for GenMAPP. Primarily, our biggest error in the the previous attempt was forgetting to account for the fact that each gene was spotted in (technical) quadruplicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Dr. Dahlquist prepared a sheet for us to start with, which separated each quadruplicate of the genome across columns. So the ID column for the first technical replicate was in column A, followed by fold change data for one of the four technical replicates within each of the biological replicates, for the (untreated) biofilm and tobramycin-treated biofilm samples. Next was the second ID column (identical to the first) in column J, followed by the second set of technical replicates within each biological replicate. These sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;quadruplicated_spots_separated&amp;#039;&amp;#039;&amp;#039;&amp;quot;.&lt;br /&gt;
# After all four sets of technical replicates, yet another ID column (column AK) was added, following by the averaged fold change values across each technical replicate (for each biological replicate - columns AL through AS). &lt;br /&gt;
#* For these averages the &amp;lt;code&amp;gt;=AVERAGE(*four technical replicates*)&amp;lt;/code&amp;gt; command was used and pasted through the entirety of each column. The *four technical replicates* is a placeholder for the cell coordinates corresponding to each technical replicate within a biological replicate.&lt;br /&gt;
#* Because all five untreated and all three treated samples will be averaged later in the protocol, the word &amp;quot;consolidated&amp;quot; (instead of &amp;quot;average&amp;quot;) was used in the headings for these columns. For example, the column heading for the first biological untreated sample was &amp;quot;consolidated_Biofilm_1_scaled_centered_4&amp;quot;.&lt;br /&gt;
# Next, a new sheet was created, named &amp;quot;&amp;#039;&amp;#039;&amp;#039;statistics&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet (using the &amp;quot;Paste Values&amp;quot; function) were the &amp;quot;consolidated&amp;quot; columns (preceded by the ID column). Thus, the ID&amp;#039;s were in column A while the consolidated fold changes for each biological replicate were in columns B through J. The average across the five untreated samples were calculated in column K (using the previously mentioned command), with the header &amp;quot;AVG_Biofilm_scaled_centered&amp;quot;. In column L, the same was done using the three treated samples.&lt;br /&gt;
# In column M, the ratios between the averages for treated and untreated samples were calculated. However, because these fold changes are in log space the fold changes for the treated samples were &amp;#039;&amp;#039;subtracted&amp;#039;&amp;#039; from that of the untreated samples.&lt;br /&gt;
#* An example command for the gene in 2, is &amp;lt;code&amp;gt;=L2-K2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Next, the p-value&amp;#039;s for each fold change ratio was calculated. A type-3, 2-tailed T-test was used.&lt;br /&gt;
#* The command for the first gene (row 2) is &amp;lt;code&amp;gt;=TTEST(C2:G2,H2:J2,2,3)&amp;lt;/code&amp;gt;. As before, this was pasted through all genes.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;bonferroni_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;There are 7251 genes in the sheet.&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
*How many genes have p value &amp;lt; 0.05? And what is the percentage?&lt;br /&gt;
** 4318, ~60%&lt;br /&gt;
*What about p &amp;lt; 0.01?&lt;br /&gt;
** 2971, ~41%&lt;br /&gt;
*What about p &amp;lt; 0.001? &lt;br /&gt;
** 1460, ~20%&lt;br /&gt;
*What about p &amp;lt; 0.0001?&lt;br /&gt;
** 645, ~9%&lt;br /&gt;
&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Bonferroni-corrected p value? &lt;br /&gt;
** 179, ~2.4%&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Benjamini and Hochberg-corrected p value? &lt;br /&gt;
** 609, ~8.4%&lt;br /&gt;
&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0. &lt;br /&gt;
** &lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.&lt;br /&gt;
**&lt;br /&gt;
&lt;br /&gt;
This is a more realistic values for the fold change cut-offs because it represents about a 20% fold change which is about the level of detection of this technology:&lt;br /&gt;
*&amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05.&lt;br /&gt;
**&lt;br /&gt;
*&amp;quot;Biofilm_tobramycin_ratio&amp;quot; &amp;lt; -0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05. &lt;br /&gt;
**&lt;br /&gt;
&lt;br /&gt;
== Links ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
{{Template:KwyllieJournalLinks}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Journal Entry]]&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7330</id>
		<title>Kevin Wyllie Week 14</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7330"/>
				<updated>2015-12-07T01:38:50Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Continued the protocol.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== Statistical Analysis and Formatting === &lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;We looked at Dr. Dahlquist&amp;#039;s comments on our prior worksheet to make a second attempt at processing and formatting for GenMAPP. Primarily, our biggest error in the the previous attempt was forgetting to account for the fact that each gene was spotted in (technical) quadruplicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Dr. Dahlquist prepared a sheet for us to start with, which separated each quadruplicate of the genome across columns. So the ID column for the first technical replicate was in column A, followed by fold change data for one of the four technical replicates within each of the biological replicates, for the (untreated) biofilm and tobramycin-treated biofilm samples. Next was the second ID column (identical to the first) in column J, followed by the second set of technical replicates within each biological replicate. These sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;quadruplicated_spots_separated&amp;#039;&amp;#039;&amp;#039;&amp;quot;.&lt;br /&gt;
# After all four sets of technical replicates, yet another ID column (column AK) was added, following by the averaged fold change values across each technical replicate (for each biological replicate - columns AL through AS). &lt;br /&gt;
#* For these averages the &amp;lt;code&amp;gt;=AVERAGE(*four technical replicates*)&amp;lt;/code&amp;gt; command was used and pasted through the entirety of each column. The *four technical replicates* is a placeholder for the cell coordinates corresponding to each technical replicate within a biological replicate.&lt;br /&gt;
#* Because all five untreated and all three treated samples will be averaged later in the protocol, the word &amp;quot;consolidated&amp;quot; (instead of &amp;quot;average&amp;quot;) was used in the headings for these columns. For example, the column heading for the first biological untreated sample was &amp;quot;consolidated_Biofilm_1_scaled_centered_4&amp;quot;.&lt;br /&gt;
# Next, a new sheet was created, named &amp;quot;&amp;#039;&amp;#039;&amp;#039;statistics&amp;#039;&amp;#039;&amp;#039;&amp;quot;. Pasted into this sheet (using the &amp;quot;Paste Values&amp;quot; function) were the &amp;quot;consolidated&amp;quot; columns (preceded by the ID column). Thus, the ID&amp;#039;s were in column A while the consolidated fold changes for each biological replicate were in columns B through J. The average across the five untreated samples were calculated in column K (using the previously mentioned command), with the header &amp;quot;AVG_Biofilm_scaled_centered&amp;quot;. In column L, the same was done using the three treated samples.&lt;br /&gt;
# In column M, the ratios between the averages for treated and untreated samples were calculated. However, because these fold changes are in log space the fold changes for the treated samples were &amp;#039;&amp;#039;subtracted&amp;#039;&amp;#039; from that of the untreated samples.&lt;br /&gt;
#* An example command for the gene in 2, is &amp;lt;code&amp;gt;=L2-K2&amp;lt;/code&amp;gt;.&lt;br /&gt;
# Next, the p-value&amp;#039;s for each fold change ratio was calculated. A type-3, 2-tailed T-test was used.&lt;br /&gt;
#* The command for the first gene (row 2) is &amp;lt;code&amp;gt;=TTEST(C2:G2,H2:J2,2,3)&amp;lt;/code&amp;gt;. As before, this was pasted through all genes.&lt;br /&gt;
# The next sheet was named &amp;quot;&amp;#039;&amp;#039;&amp;#039;bonferroni_pval&amp;#039;&amp;#039;&amp;#039;&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;There are 7251 genes in the sheet.&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
*How many genes have p value &amp;lt; 0.05? And what is the percentage?&lt;br /&gt;
** 4318, ~60%&lt;br /&gt;
*What about p &amp;lt; 0.01?&lt;br /&gt;
** 2971, ~41%&lt;br /&gt;
*What about p &amp;lt; 0.001? &lt;br /&gt;
** 1460, ~20%&lt;br /&gt;
*What about p &amp;lt; 0.0001?&lt;br /&gt;
** 645, ~9%&lt;br /&gt;
&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Bonferroni-corrected p value? &lt;br /&gt;
** 179, ~2.4%&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Benjamini and Hochberg-corrected p value? &lt;br /&gt;
** 609, ~8.4%&lt;br /&gt;
&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0. &lt;br /&gt;
** &lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.&lt;br /&gt;
**&lt;br /&gt;
&lt;br /&gt;
This is a more realistic values for the fold change cut-offs because it represents about a 20% fold change which is about the level of detection of this technology:&lt;br /&gt;
*&amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05.&lt;br /&gt;
**&lt;br /&gt;
*&amp;quot;Biofilm_tobramycin_ratio&amp;quot; &amp;lt; -0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05. &lt;br /&gt;
**&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7272</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=7272"/>
				<updated>2015-12-05T21:20:02Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added our first exceptions file.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
*Further explore the various ID systems; verify previous findings&lt;br /&gt;
*Create expressions for Match/PGSQL that will assist in evaluating the quality of any exported databases&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Completed Milestone 1: Initial Database Export&lt;br /&gt;
*Completed Milestone 2: ID Pattern Definition and Verification (will be revisited for future work with modified forms of GenMAPP builder) &lt;br /&gt;
**Should talk to Anu about further steps involving TallyEngine/GenMAPP builder (organize more exports)&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:WEEK12FILES GEN BL.zip|Week 12 Files]]&lt;br /&gt;
*[[Media:ORIG GEN BL12.zip|Starting Files]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Week 14=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finish second build.&lt;br /&gt;
* Analyze results from previous build with Brandon Litvak and determine modifications that need to be made to code.&lt;br /&gt;
* Begin modifying code to collect gene names from &amp;quot;ORF&amp;quot; instead of &amp;quot;OrderedLocusTags&amp;quot;&lt;br /&gt;
* Start writing README and scientific paper (parts of deliverables).&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Perform database export on the second build and other builds of the customized genMAPP builder&lt;br /&gt;
* Determine, with Anu, what modifications must be done to GenMAPP builder/Tallyengine&lt;br /&gt;
* Find out why most of the data/gene-names were not captured in the &amp;quot;OrderedLocusNames&amp;quot; table of the PSQL database for Export 1&lt;br /&gt;
* Perform testing report on any builds created for the week.&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Perform the statistical analysis in Excel.&lt;br /&gt;
*Format the gene expression data for import into GenMAPP.&lt;br /&gt;
*Import data into GenMAPP, create ColorSets, and run MAPPFinder.&lt;br /&gt;
*Document and take notes on test runs with GenMAPP.&lt;br /&gt;
*Use the EX.txt file to help the Coder/Quality Assurance team members to validate the .gdb.&lt;br /&gt;
*Do a journal club outline of the paper so that you can use it in the Discussion section of your group report and your final presentation.&lt;br /&gt;
Create a .mapp file showing one pathway that is changed in your data.&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Finished second build. &lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 14]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 14]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 14]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 14]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
Build 2 - with customized species profile:&lt;br /&gt;
* [[Media: Gmbuilder-genialomics-12012015-build-2.zip| gmbuilder-genialomics-12012015-build-2.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:22, 1 December 2015 (PST) &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 3 - picking up gene names from ORF instead of ordered locus&lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-3.zip | gmbuilder-genialomics-12032015-build-3.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 14:58, 3 December 2015 (PST)&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Build 4 - customized TallyEngine &lt;br /&gt;
* [[Media:Gmbuilder-genialomics-12032015-build-4.zip|gmbuilder-genialomics-12032015-build-4.zip]]&lt;br /&gt;
[[User:Anuvarsh|Anuvarsh]] ([[User talk:Anuvarsh|talk]]) 15:18, 3 December 2015 (PST)&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Media:Bc-Std_GEN_20151204.zip|Compressed gdb from Build 4]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; [[media:For_genMAPP_KWVP20151205.EX.txt|Exceptions file from first export.]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=Deliverables=&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:For_genMAPP_KWVP20151205.EX.txt&amp;diff=7271</id>
		<title>File:For genMAPP KWVP20151205.EX.txt</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:For_genMAPP_KWVP20151205.EX.txt&amp;diff=7271"/>
				<updated>2015-12-05T21:18:56Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: The exceptions file for our first export.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The exceptions file for our first export.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7195</id>
		<title>Kevin Wyllie Week 14</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Kevin_Wyllie_Week_14&amp;diff=7195"/>
				<updated>2015-12-03T23:52:11Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Began protocol and sanity check. Very incomplete at this point, though.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Electronic Lab Notebook == &lt;br /&gt;
&lt;br /&gt;
=== Statistical Analysis and Formatting === &lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;We looked at Dr. Dahlquist&amp;#039;s comments on our prior worksheet to make a second attempt at processing and formatting for GenMAPP. Primarily, our biggest error in the the previous attempt was forgetting to account for the fact  that each gene was spotted in (technical) quadruplicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
* Dr. Dahlquist prepared a sheet for us to start with, which separated each quadruplicate of the genome across columns. So the ID column for the first technical replicate is in A1, followed by&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== Sanity Check ===&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;There are 7251 genes in the sheet.&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
*How many genes have p value &amp;lt; 0.05? And what is the percentage?&lt;br /&gt;
** 4318, ~60%&lt;br /&gt;
*What about p &amp;lt; 0.01?&lt;br /&gt;
** 2971, ~41%&lt;br /&gt;
*What about p &amp;lt; 0.001? &lt;br /&gt;
** 1460, ~20%&lt;br /&gt;
*What about p &amp;lt; 0.0001?&lt;br /&gt;
** 645, ~9%&lt;br /&gt;
&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Bonferroni-corrected p value? &lt;br /&gt;
** 179, ~2.4%&lt;br /&gt;
*How many genes are p &amp;lt; 0.05 for the Benjamini and Hochberg-corrected p value? &lt;br /&gt;
** 609, ~8.4%&lt;br /&gt;
&lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0. &lt;br /&gt;
** &lt;br /&gt;
*&amp;quot;Pvalue&amp;quot; &amp;lt; 0.05, and &amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.&lt;br /&gt;
**&lt;br /&gt;
&lt;br /&gt;
This is a more realistic values for the fold change cut-offs because it represents about a 20% fold change which is about the level of detection of this technology:&lt;br /&gt;
*&amp;quot;Biofilm_Tobramycin_ratio&amp;quot; &amp;gt; 0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05.&lt;br /&gt;
**&lt;br /&gt;
*&amp;quot;Biofilm_tobramycin_ratio&amp;quot; &amp;lt; -0.25 and &amp;quot;Pvalue&amp;quot; &amp;lt; 0.05. &lt;br /&gt;
**&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Template:KwyllieJournalLinks&amp;diff=7138</id>
		<title>Template:KwyllieJournalLinks</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=Template:KwyllieJournalLinks&amp;diff=7138"/>
				<updated>2015-12-03T22:38:06Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Fixed a missing link!&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[User:kwyllie]]&lt;br /&gt;
* [[Kevin Wyllie Week 2]] (See the [[Week 2|original assignment]] and [[Class Journal Week 2|class journal]].)&lt;br /&gt;
* [[Kevin Wyllie Week 3]] (See the [[Week 3|original assignment]] and [[Class Journal Week 3|class journal]].)&lt;br /&gt;
* [[Kevin Wyllie Week 4]] (See the [[Week 4|original assignment]] and [[Class Journal Week 4|class journal]].)&lt;br /&gt;
* [[Kevin Wyllie Week 5]] (See the [[Week 5|original assignment]] and [[Class Journal Week 5|class journal]].)&lt;br /&gt;
* [[Kevin Wyllie Week 6]] (See the [[Week 6|original assignment]] and [[Class Journal Week 6|class journal]].)&lt;br /&gt;
* [[Kevin Wyllie Week 7]] (See the [[Week 7|original assignment]] and [[Class Journal Week 7|class journal]].)&lt;br /&gt;
* [[Kevin Wyllie Week 8]] (See the [[Week 8|original assignment]] and [[Class Journal Week 8|class journal]].)&lt;br /&gt;
* [[Kevin Wyllie Week 9]] (See the [[Week 9|original assignment]] and [[Class Journal Week 9|class journal]].)&lt;br /&gt;
* [[Kevin Wyllie Week 10]] (See the [[Week 10|original assignment]].)&lt;br /&gt;
* [[Kevin Wyllie Week 11]] (See the [[Week 11|original assignment]].)&lt;br /&gt;
* [[Kevin Wyllie Week 12]] (See the [[Week 12|original assignment]].)&lt;br /&gt;
* [[Kevin Wyllie Week 14]] (See the [[Week 14|original assignment]].)&lt;br /&gt;
* [[Kevin Wyllie Week 15]] (See the [[Week 14|original assignment]].)&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=6899</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=6899"/>
				<updated>2015-11-24T04:52:01Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added download link for the spreadsheet containing our progress in analyzing the microarray data.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
[[Media:Raw_compiled_data_KW20151119.xlsx]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:Raw_compiled_data_KW20151119.xlsx&amp;diff=6897</id>
		<title>File:Raw compiled data KW20151119.xlsx</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=File:Raw_compiled_data_KW20151119.xlsx&amp;diff=6897"/>
				<updated>2015-11-24T04:50:59Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Our progress in compiling and processing the data.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Our progress in compiling and processing the data.&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	<entry>
		<id>https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=6894</id>
		<title>GENialOMICS</title>
		<link rel="alternate" type="text/html" href="https://xmlpipedb.lmucs.io/biodb/fall2015/index.php?title=GENialOMICS&amp;diff=6894"/>
				<updated>2015-11-24T04:49:13Z</updated>
		
		<summary type="html">&lt;p&gt;Kwyllie: Added progress for this week.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image: Genialomics-banner.jpg | center | 1055px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{{Template:GÉNialOMICS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 10=&lt;br /&gt;
*On November 3, 2015, GÉNialOMICS chose to create database for &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039;.&lt;br /&gt;
*On November 5, 2015, a journal detailing the complete genome of &amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients]  was found.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Week 11=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete journal club individual assignment&lt;br /&gt;
* Create and practice journal club presentation with Brandon&lt;br /&gt;
* Find a MOD&lt;br /&gt;
* Create project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
* Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Reformat Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Perform an initial import/export cycle (with Anu)&lt;br /&gt;
*Figure out a file management system (with Anu)&lt;br /&gt;
*Characterize regular expression patterns for ID detection&lt;br /&gt;
*Further explore the found MOD and review it&lt;br /&gt;
*Complete Journal Club presentation on the genome paper&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
* Understand experimental design&lt;br /&gt;
* Understand sample-data relationship&lt;br /&gt;
** raw.zip and .sdrf&lt;br /&gt;
** Construct sample-data diagram&lt;br /&gt;
* Develop compiled raw data file&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*Found a possible [http://www.burkholderia.com/ model organism database] (with Brandon Litvak)&lt;br /&gt;
*The journal club presentation and outline was prepared; MOD was examined and reviewed&lt;br /&gt;
* Completed journal club individual assignment&lt;br /&gt;
* Created and practice journal club presentation with Brandon&lt;br /&gt;
* Found a MOD&lt;br /&gt;
* Created project timeline with soft deadlines for each person/milestone&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Reformatted Home Page with Dr. Dahlquists recommendations&lt;br /&gt;
* Journal Club Presentation File: [[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf|Genome Presentation]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
* Found a possible [http://www.burkholderia.com/ model organism database].&lt;br /&gt;
**The more recent [http://beta.burkholderia.com/ version] of the MOD was found&lt;br /&gt;
*The regular expression patterns for J2315 were determined&lt;br /&gt;
*Preparation was done for the Genome Paper Presentation&lt;br /&gt;
**Completed outline of the genome paper&lt;br /&gt;
*File management system was determined&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt; Created methods diagram ([[media:KWVPMethoddiagram.jpg]]).&lt;br /&gt;
*[[File:B. Cenopacia.pptx]]&lt;br /&gt;
* we understood the experimental design&lt;br /&gt;
* made chart for microarray experiment&lt;br /&gt;
*finished powerpoint on microarray paper&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 11]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 11]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 11]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 11]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==File Management System==&lt;br /&gt;
*Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where &amp;quot;XXXX&amp;quot; is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)&lt;br /&gt;
*Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)&lt;br /&gt;
*All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label &amp;quot;ORIGINAL FILES&amp;quot;&lt;br /&gt;
==Other Progress==&lt;br /&gt;
* A journal using the &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; genome in a microarray experiment titled [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/ Biofilm-Grown &amp;#039;&amp;#039;Burkholderia cepacia&amp;#039;&amp;#039; Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species] was approved for analysis.&lt;br /&gt;
&lt;br /&gt;
==Journal Club Presentations==&lt;br /&gt;
[[Media:Genome_Presentation_-_Anu_and_Brandon_-_Genialomics(FIXED).pdf| Genome Paper Presentation Week 11]]&amp;lt;br&amp;gt;&lt;br /&gt;
[[Media:B._Cenopacia.pptx| Microarray Paper Presentation Week 12]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Week 12=&lt;br /&gt;
==Individual Goals and Progress==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;margin: auto;&amp;quot;&lt;br /&gt;
!colspan=&amp;quot;9&amp;quot;|Weekly Goals and Progress&lt;br /&gt;
|-&lt;br /&gt;
!&lt;br /&gt;
![[User:Anuvarsh|&amp;#039;&amp;#039;&amp;#039;Anu Varshneya&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Blitvak|&amp;#039;&amp;#039;&amp;#039;Brandon Litvak&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Vpachec3|&amp;#039;&amp;#039;&amp;#039;Veronica Pacheco&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
![[User:Kwyllie|&amp;#039;&amp;#039;&amp;#039;Kevin Wyllie&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Goals&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Complete milestone 0: Working Environment Setup&lt;br /&gt;
** Set up the development machine (my laptop) with all required software for coding. &lt;br /&gt;
* Complete milestone 1: Version Control Setup&lt;br /&gt;
** Set up a branch specific to our project and clone necessary code from GitHub onto the development machine.&lt;br /&gt;
* Complete milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
** Confirm that all core software for developing, building, and testing prototype version of GenMAPP Builder are on the development machine.&lt;br /&gt;
** Set up Eclipse and java project workspace.&lt;br /&gt;
** Run initial build.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*Complete Milestone 1: Initial Database Export&lt;br /&gt;
*Create a Gene Database testing report for the initial export&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Kevin Wyllie&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;Work with Veronica Pacheco&amp;#039;&amp;#039;&lt;br /&gt;
*Read the microarray paper to understand the experiment.&lt;br /&gt;
*Create a table or list that shows the correspondence between the samples in the experiment and the files you have downloaded.&lt;br /&gt;
*Determine how many biological or technical replicates, and which samples were labeled with Cy3 or Cy5.&lt;br /&gt;
*Create a Master Raw Data file that contains the IDs and columns of data required for further analysis.&lt;br /&gt;
*Consult with Dr. Dahlquist on how to process the data (normalization, statistics).&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Progress&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
* Completed milestone 0: Working Environment Setup&lt;br /&gt;
* Completed milestone 1: Version Control Setup&lt;br /&gt;
* Completed milestone 2: “Developer Rig” Setup and Initial As-Is Build&lt;br /&gt;
* Began milestone 3: Species Profile Creation&lt;br /&gt;
** Need to consult with Brandon and/or Dr. Dionisio before continuing.&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
* Compiled data into one Excel spreadsheet. &lt;br /&gt;
* Centered data and began statistical analysis (stopped at T statistic). &lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Individual Journal Pages&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
*[[Anuvarsh Week 12]]&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
*[[Blitvak Week 12]]&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
*[[Vpachec3 Week 12]]&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
*[[Kevin Wyllie Week 12]]&lt;br /&gt;
|-&lt;br /&gt;
!scope=&amp;quot;row&amp;quot;|&amp;#039;&amp;#039;&amp;#039;Files Used/Created&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;lt;!--Anu--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Brandon--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Veronica--&amp;gt;&lt;br /&gt;
|&amp;lt;!--Kevin--&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Other Progress==&lt;br /&gt;
&lt;br /&gt;
=&amp;#039;&amp;#039;Burkholderia cenocepacia&amp;#039;&amp;#039; Genome Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients  . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/18931103]&lt;br /&gt;
* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612433/]&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site. [http://jb.asm.org/content/191/1/261.long]&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site. [http://jb.asm.org/content/191/1/261.full.pdf+html]&lt;br /&gt;
* Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology which is a scientific society&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;It is both available in print and online.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It has 150 cited references.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;It is cited 128 times.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;A lot of the papers revolved around antibiotic resistance and therapeutic strategies.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
=Microarray Paper=&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... &amp;amp; Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. &amp;#039;&amp;#039;PLoS One&amp;#039;&amp;#039;, 8(3), e58943.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* This article is suitable for your project.  &amp;#039;&amp;#039;&amp;amp;mdash; [[User:Kdahlquist|Kdahlquist]] ([[User talk:Kdahlquist|talk]]) 10:17, 10 November 2015 (PST)&amp;#039;&amp;#039;&lt;br /&gt;
* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species&lt;br /&gt;
* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/&lt;br /&gt;
* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943&lt;br /&gt;
**Cannot find HTML format on publisher web site.&lt;br /&gt;
* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&amp;amp;representation=PDF&lt;br /&gt;
* Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye&lt;br /&gt;
* Does the journal own the copyright? Yes.&lt;br /&gt;
* Do the authors own the copyright? No.&lt;br /&gt;
* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
* Is the article available “Open Access”? Yes.&lt;br /&gt;
* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.&lt;br /&gt;
* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.&lt;br /&gt;
* How many articles does this article cite? This article has 34 cited references.&lt;br /&gt;
* How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.&lt;br /&gt;
* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to  antimicrobial therapy, tolerance, and resistance.&lt;br /&gt;
&amp;lt;!-- #&amp;#039;&amp;#039;&amp;#039;Sass, A., Marchbank, A., Tullis, E., LiPuma, J. J., &amp;amp; Mahenthiralingam, E. (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. &amp;#039;&amp;#039;BMC genomics&amp;#039;&amp;#039;, 12(1), 373. doi:10.1186/1471-2164-12-373&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Transcriptomic analysis was performed using the following strains, after exposure to different antibiotics in the presence of an antibiotic potentiator:&lt;br /&gt;
#** Control: the wild-type J2315 strain&lt;br /&gt;
#** Treatment: mutant strains which showed antibiotic resistance&lt;br /&gt;
#** Treatment: ET12 outbreak isolates, described as &amp;quot;pan-resistant&amp;quot;&lt;br /&gt;
#* Three biological replicates were used for each experiment.&lt;br /&gt;
#* The raw data does not appear to be directly linked from the article itself. The supplement includes a summary spreadsheet, which only displays values for fold-changes that were statistically significant. However both the raw and processed data files are available on the [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2747/files/ ArrayExpress entry].&lt;br /&gt;
#* PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/21781329&lt;br /&gt;
#* PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155924/&lt;br /&gt;
#* Publisher Full Text (HTML): http://www.biomedcentral.com/1471-2164/12/373&lt;br /&gt;
#* Publisher Full Text (PDF):  http://www.biomedcentral.com/content/pdf/1471-2164-12-373.pdf&lt;br /&gt;
#* Copyright:  2011 Sass et al; licensee BioMed Central Ltd. &amp;quot;This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&amp;quot;&lt;br /&gt;
#* Publisher:  BioMedCentral, respected Open Access organization.&lt;br /&gt;
#* Availability:  Article does not initially appear to be available in print, however, BioMedCentral&amp;#039;s website mentions that &amp;quot;high quality, bound reprints&amp;quot; can be purchased for any published article.&lt;br /&gt;
#* Did LMU pay a fee for this article: No - open access.&lt;br /&gt;
#* This article cites 64 other articles.&lt;br /&gt;
#* This article has been cited by 29 other articles (across all databases).&lt;br /&gt;
#* The scientific community seems to be particularly interested in this organism&amp;#039;s antimicrobial resistance, probably because this is a known pathogen, particularly relevant in the context of cystic fibrosis.&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Mira, N. P., Madeira, A., Moreira, A. S., Coutinho, C. P., &amp;amp; Sá-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients’ airways and antimicrobial therapy. PLoS One, 6(12), e28831.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Genomic+Expression+Analysis+Reveals+Strategies+of+Burkholderia+cenocepacia+to+Adapt+to+Cystic+Fibrosis+Patients%27+Airways+and+Antimicrobial+Therapy&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244429/&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028831&lt;br /&gt;
#**Cannot find HTML format on publisher web site.&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0028831&amp;amp;representation=PDF&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: Nuno P. Mira, Andreia Madeira, Ana Sílvia Moreira, Carla P. Coutinho, Isabel Sá-Correia&lt;br /&gt;
#* Does the journal own the copyright? Yes.&lt;br /&gt;
#* Do the authors own the copyright? No.&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? Yes.&lt;br /&gt;
#* Is the article available “Open Access”? Yes.&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-809/?keywords=&amp;amp;organism=Burkholderia+cenocepacia&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? The &amp;quot;treatments&amp;quot; strains were collected from a cystic fibrosis patient. The strain &amp;quot;IST439&amp;quot; was collected first, and the strain &amp;quot;IST4113&amp;quot; was collected 3 years later. The control for this experiment is reference data of Burkholderia cenocepacia.&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? There were 3 replicates of each of the 2 strains and 6 replicates of the reference strain. It is unclear whether these are biological or technical replicates.&lt;br /&gt;
#* How many articles does this article cite? This article has 75 cited references.&lt;br /&gt;
#* How many articles cite this article? This article has been cited 22 times in All Databases, and 22 times in Web of Science Core Collection.&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most articles are related to Burkholderia&amp;#039;s pathogenesis and antibiotic resistance.&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Yoder-Himes, D. R., Konstantinidis, K. T., &amp;amp; Tiedje, J. M. (2010). Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One, 5(1), e8724.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20090946&lt;br /&gt;
#* PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806911/&lt;br /&gt;
#* Publisher Full Text (HTML): http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008724&lt;br /&gt;
#* Publisher Full Text (PDF): http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0008724&amp;amp;representation=PDF&lt;br /&gt;
#* Copyright: &amp;#039;&amp;#039;&amp;#039;© 2010 Yoder-Himes et al&amp;#039;&amp;#039;&amp;#039; (information found on PDF version of article); the article is open-access and is distributed under a &amp;#039;&amp;#039;&amp;#039;Creative Commons license&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Publisher: &amp;#039;&amp;#039;&amp;#039;PLOS&amp;#039;&amp;#039;&amp;#039; (Public Library of Science); nonprofit open-access publisher/advocate             &lt;br /&gt;
#* Availability: &amp;#039;&amp;#039;&amp;#039;online only&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Did LMU pay a fee for this article: &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Data Found At: [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15817/ ArrayExpress]&lt;br /&gt;
#* Experiment Information: The transcriptome of a clinical and a environmental strain of &amp;#039;&amp;#039;B. cenocepacia&amp;#039;&amp;#039; was analyzed under conditions mimicking soil versus conditions mimicking the sputum resulting from cystic fibrosis. Identification and observation related to putative virulence factors was conducted. &amp;quot;Treatment&amp;quot; conditions were those mimicking CF sputum and &amp;quot;Control&amp;quot; conditions were those mimicking soil.&lt;br /&gt;
#* Replicate Information: Replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; were conducted (quadruplicates were employed using different cultures). These were biological replicates (total of 8 arrays, &amp;#039;&amp;#039;&amp;#039;four biological replicates&amp;#039;&amp;#039;&amp;#039;).&lt;br /&gt;
#* How many articles does this article cite: &amp;#039;&amp;#039;&amp;#039;61&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article: &amp;#039;&amp;#039;&amp;#039;14&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The papers that cite this article appear to focus upon the aspects of the J2315 strain and other BCC bacteria that are related to virulence and host-pathogen interactions. A few articles also explored the role of certain genes which are related to the pathogenic character of the strain (which were possibly examined in the paper by Yoder-Himes et al).&lt;br /&gt;
#&amp;#039;&amp;#039;&amp;#039;Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., &amp;amp; Mahenthiralingam, E. (2011). Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy, 55(5), 1912–1919. http://doi.org/10.1128/AAC.01571-10&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* State what you used as search terms and what type of search terms they were. &amp;#039;&amp;#039;&amp;#039;Used the search bar in Array Express and used the terms Burkholderia cenocepacia J2315. I used the filters RNA assay and Array assay.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many results did you get? &amp;#039;&amp;#039;&amp;#039;There were 18 experiments that resulted in the search.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Give an assessment of how relevant the results were. &amp;#039;&amp;#039;&amp;#039;A good chunk of the experiments we weren&amp;#039;t going to look at because the assay numbers were smaller than 9 which was as low as we were going to test.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from  [http://www.ncbi.nlm.nih.gov/pubmed PubMed]. [http://www.ncbi.nlm.nih.gov/pubmed/21357299?dopt=Abstract]&lt;br /&gt;
#* The link to the full text of the article in [http://www.ncbi.nlm.nih.gov/pmc/ PubMedCentral]. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088199/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site. [http://aac.asm.org/content/55/5/1912.full]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site. [http://aac.asm.org/content/55/5/1912.full.pdf+html]&lt;br /&gt;
#*Who owns the rights to the article? &amp;#039;&amp;#039;&amp;#039;American Society for Microbiology&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a [http://creativecommons.org/ Creative Commons] license? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article?  What type of organization is it?  (commercial, for-profit publisher, scientific society, respected open access organization like [http://www.plos.org/ Public Library of Science] or [http://www.plos.org/ BioMedCentral], or predatory open access organization, see the list of) [http://oaspa.org/membership/members/ (Open Access Scholarly Publishers Association Members) here.] &amp;#039;&amp;#039;&amp;#039;American Society For Microbiology which is a scientific society.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? &amp;#039;&amp;#039;&amp;#039;Both online and in print.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;It sites 36 other articles.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;32 on Google Scholar and 22 on Web of Science&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced?&lt;br /&gt;
#* In addition, you must also link to the web site where the microarray data resides.[ https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2502/?keywords=Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* For each of the microarray articles/datasets, answer the following:&lt;br /&gt;
#* What experiment was performed?  What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;B. cenocepacia J2315 cells were treated by exposure to high levels of H2O2, NaOCl or chlorhexidine. In addition differences in gene expression were examined between untreated B. cenocepacia sessile cells and B. cenocepacia planktonic cells.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#*  Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted?  Were these biological or technical replicates?  How many of each? &amp;#039;&amp;#039;&amp;#039;There were 20 assays.Hybridizations for all experimental conditions were performed in 4 replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Drevinek, P., Holden, M. T., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T., &amp;amp; Mahenthiralingam, E. (2008). Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infectious Diseases, 8, 121. http://doi.org/10.1186/1471-2334-8-121&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* The link to the abstract from PubMed: [http://www.ncbi.nlm.nih.gov/pubmed/18801206?dopt=Abstract&amp;amp;holding=f1000,f1000m,isrctn]&lt;br /&gt;
#* The link to the full text of the article in PubMedCentral: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559838/]&lt;br /&gt;
#* The link to the full text of the article (HTML format) from the publisher web site: [http://www.biomedcentral.com/1471-2334/8/121]&lt;br /&gt;
#* The link to the full PDF version of the article from the publisher web site: [http://www.biomedcentral.com/content/pdf/1471-2334-8-121.pdf]&lt;br /&gt;
#* Who owns the rights to the article? Authors of the article: &amp;#039;&amp;#039;&amp;#039;Copyright © 2008 Drevinek et al; licensee BioMed Central Ltd.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Does the journal own the copyright? &amp;#039;&amp;#039;&amp;#039;No&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the copyright? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Do the authors own the rights under a Creative Commons license? &amp;#039;&amp;#039;&amp;#039;Yes&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
#* Is the article available “Open Access”? &amp;#039;&amp;#039;&amp;#039;Yes.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* What organization is the publisher of the article? What type of organization is it? &amp;#039;&amp;#039;&amp;#039;BMC Infectious Diseases is an open access, peer-reviewed journal&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Is this article available in print or online only? Available in print and online.&lt;br /&gt;
#* Has LMU paid a subscription or other fee for your access to this article? No.&lt;br /&gt;
#* Where does MicroArray Data reside? [https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1261/?keywords=+Burkholderia+cenocepacia+J2315&amp;amp;organism=&amp;amp;exptype%5B%5D=%22rna+assay%22&amp;amp;exptype%5B%5D=%22array+assay%22&amp;amp;array=]&lt;br /&gt;
#* What experiment was performed? What was the &amp;quot;treatment&amp;quot; and what was the &amp;quot;control&amp;quot; in the experiment? &amp;#039;&amp;#039;&amp;#039;The genome of Burkholderia cenocepacia J2315 and transcriptomics used to identify genes that were differentially regulated when the pathogen was grown in a CF sputum-based infection model. Sputum samples from CF individuals infected with the same B. cenocepacia strain as genome isolate were used, hence, other than a dilution into a minimal growth medium (used as the control condition), no further treatment of the sputum was carried out.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Were replicate experiments of the &amp;quot;treatment&amp;quot; and &amp;quot;control&amp;quot; conditions conducted? Were these biological or technical replicates? How many of each? &amp;#039;&amp;#039;&amp;#039;A replicate self-hybridization control experiment was performed. There were 8 essays and 4 biological replicates.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles does this article cite? &amp;#039;&amp;#039;&amp;#039;50 references cited.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* How many articles cite this article? &amp;#039;&amp;#039;&amp;#039;52 in Google Scholar and 44 in Web of Science.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
#* Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? &amp;#039;&amp;#039;&amp;#039;It has been working on antibiotic resistance in cystic fibrosis patients and how the bacteria had evolves and reacts to different extreme treatments.&amp;#039;&amp;#039;&amp;#039; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Kwyllie</name></author>	</entry>

	</feed>